UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q


(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, ~~2022~~2023

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 000-52566

SUMMIT HEALTHCARE REIT, INC.

(Exact name of registrant as specified in its charter)


MARYLAND	73-1721791
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

23382 MILL CREEK DRIVE, SUITE 125, LAGUNA HILLS, CA	92653
(Address of principal executive offices)	(Zip Code)

800-978-8136

(Registrant’s telephone number, including area code)

~~2 SOUTH POINTE DRIVE, SUITE 100, LAKE FOREST, CA 92630~~

~~(Former name, former address and former fiscal year, if changed since last report)~~

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Ticker symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ⌧☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ⌧☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and ~~“smaller reporting~~“emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐

Non-accelerated filer	☒	Smaller reporting company	☒

Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ⌧☒ No

As of August ~~5, 2022,~~7, 2023, we had 23,027,978 shares of common stock of Summit Healthcare REIT, Inc. outstanding.

Table of Contents

FORM 10-Q

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

TABLE OF CONTENTS


PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements:	3
	Condensed Consolidated Balance Sheets (unaudited)	3
	Condensed Consolidated Statements of Operations (unaudited)	4
	Condensed Consolidated Statements of Equity (unaudited)	5
	Condensed Consolidated Statements of Cash Flows (unaudited)	6
	Notes to Condensed Consolidated Financial Statements (unaudited)	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2723
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3931
Item 4.	Controls and Procedures	4031
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	4031
Item 1A.	Risk Factors	4032
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	4032
Item 3.	Defaults Upon Senior Securities	4032
Item 4.	Mine Safety Disclosures	4032
Item 5.	Other Information	4032
Item 6.	Exhibits	4133
SIGNATURES		4234

EX-31.1
EX-31.2
EX-32

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements.

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)


	June 30,		December 31,		June 30,		December 31,
	2022		2021		2023		2022
ASSETS
Cash and cash equivalents	$	13,067,000	$	10,488,000	$	11,138,000	$	11,572,000
Restricted cash		2,700,000		2,673,000		2,922,000		2,591,000
Real estate properties, net		176,181,000		179,102,000		170,158,000		173,127,000
Intangible lease assets, net		14,196,000		14,687,000		13,213,000		13,704,000
Tenant and other receivables, net		4,260,000		3,386,000		5,571,000		5,020,000
Deferred leasing commissions, net		418,000		466,000
Other assets, net		1,519,000		422,000		2,098,000		2,107,000
Equity-method investments		7,523,000		7,902,000		5,152,000		5,182,000
Total assets	$	219,864,000	$	219,126,000	$	210,252,000	$	213,303,000

LIABILITIES AND EQUITY
Accounts payable and accrued liabilities	$	5,888,000	$	2,551,000	$	6,289,000	$	5,585,000
Security deposits		4,650,000		4,651,000		4,651,000		4,651,000
Loans payable, net of debt issuance costs		180,276,000		180,370,000		180,054,000		180,169,000
Total liabilities		190,814,000		187,572,000		190,994,000		190,405,000

Commitments and contingencies

Stockholders’ Equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued or outstanding at June 30, 2022 and December 31, 2021		—		—
Common stock, $0.001 par value; 290,000,000 shares authorized; 23,027,978 shares issued and outstanding at June 30, 2022 and December 31, 2021		23,000		23,000
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding at June 30, 2023 and December 31, 2022						—		—
Common stock, $0.001 par value; 290,000,000 shares authorized; 23,027,978 shares issued and outstanding at June 30, 2023 and December 31, 2022						23,000		23,000
Additional paid-in capital		116,415,000		116,401,000		116,449,000		116,432,000
Accumulated deficit		(87,560,000)		(85,041,000)		(97,391,000)		(93,734,000)
Total stockholders’ equity		28,878,000		31,383,000		19,081,000		22,721,000
Noncontrolling interests		172,000		171,000		177,000		177,000
Total equity		29,050,000		31,554,000		19,258,000		22,898,000
Total liabilities and equity	$	219,864,000	$	219,126,000	$	210,252,000	$	213,303,000

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Table of Contents

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)


	Three Months Ended				Six Months Ended				Three Months Ended				Six Months Ended
	June 30,				June 30,				June 30,				June 30,
	2022		2021		2022		2021		2023		2022		2023		2022
Revenues:
Total rental revenues	$	5,435,000	$	1,284,000	$	10,976,000	$	2,208,000	$	5,380,000	$	5,435,000	$	10,747,000	$	10,976,000
Resident fees and services		863,000		—		1,271,000		—		1,633,000		863,000		3,002,000		1,271,000
Acquisition and asset management fees		165,000		295,000		330,000		624,000		147,000		165,000		295,000		330,000
Interest income from notes receivable		—		4,000		—		13,000
Total operating revenue		6,463,000		1,583,000		12,577,000		2,845,000		7,160,000		6,463,000		14,044,000		12,577,000

Expenses:
Property operating costs		766,000		210,000		1,539,000		430,000		746,000		766,000		1,552,000		1,539,000
Resident costs		818,000		—		1,193,000		—		1,056,000		818,000		2,266,000		1,193,000
General and administrative		1,132,000		862,000		2,180,000		2,493,000		1,091,000		1,132,000		2,200,000		2,180,000
Depreciation and amortization		1,848,000		393,000		3,685,000		792,000		1,810,000		1,848,000		3,615,000		3,685,000
Total operating expenses		4,564,000		1,465,000		8,597,000		3,715,000		4,703,000		4,564,000		9,633,000		8,597,000

Operating income (loss)		1,899,000		118,000		3,980,000		(870,000)
Operating income										2,457,000		1,899,000		4,411,000		3,980,000

Loss from equity-method investees		(1,131,000)		(550,000)		(489,000)		(785,000)
Gain on sale of equity-method investment		—		3,515,000		—		3,515,000
Income (loss) from equity-method investees										117,000		(1,131,000)		242,000		(489,000)
Other income		161,000		6,000		163,000		11,000		100,000		161,000		196,000		163,000
Interest expense		(3,105,000)		(516,000)		(6,136,000)		(1,038,000)		(4,336,000)		(3,105,000)		(8,470,000)		(6,136,000)
Net (loss) income		(2,176,000)		2,573,000		(2,482,000)		833,000
Net loss										(1,662,000)		(2,176,000)		(3,621,000)		(2,482,000)
Noncontrolling interests’ share in net (income) loss		(18,000)		(22,000)		(37,000)		(40,000)		(19,000)		(18,000)		(36,000)		(37,000)
Net (loss) income applicable to common stockholders	$	(2,194,000)	$	2,551,000	$	(2,519,000)	$	793,000
Net loss applicable to common stockholders									$	(1,681,000)	$	(2,194,000)	$	(3,657,000)	$	(2,519,000)

Earnings per common share:
Basic:
(Loss) income	$	(0.10)	$	0.11	$	(0.11)	$	0.03
Net (loss) income applicable to common stockholders	$	(0.10)	$	0.11	$	(0.11)	$	0.03
Basic and diluted loss per common share:
Net loss applicable to common stockholders									$	(0.07)	$	(0.10)	$	(0.16)	$	(0.11)

Diluted:
(Loss) income	$	(0.10)	$	0.11	$	(0.11)	$	0.03
Net (loss) income applicable to common stockholders	$	(0.10)	$	0.11	$	(0.11)	$	0.03

Weighted average shares used to calculate earnings per common share
Basic		23,027,978		23,027,978		23,027,978		23,027,978
Diluted		23,027,978		23,553,606		23,027,978		23,553,606
Weighted average shares used to calculate basic and diluted earnings per common share										23,027,978		23,027,978		23,027,978		23,027,978

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Table of Contents

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(Unaudited)


	Common Stock													Common Stock
		Common													Common
	Number	Stock		Additional				Total						Number	Stock		Additional				Total
	of	Par		Paid-In		Accumulated		Stockholders’		Noncontrolling		Total		of	Par		Paid-In		Accumulated		Stockholders’		Noncontrolling		Total
	Shares	Value		Capital		Deficit		Equity		Interests		Equity		Shares	Value		Capital		Deficit		Equity		Interests		Equity
Balance — January 1, 2022	23,027,978	$	23,000	$	116,401,000	$	(85,041,000)	$	31,383,000	$	171,000	$	31,554,000
Balance — January 1, 2023														23,027,978	$	23,000	$	116,432,000	$	(93,734,000)	$	22,721,000	$	177,000	$	22,898,000
Stock-based compensation	0		0		8,000		0		8,000		0		8,000	—		—		7,000		—		7,000		—		7,000
Distributions paid to noncontrolling interests	0		0		0		0		0		(18,000)		(18,000)	—		—		—		—		—		(17,000)		(17,000)
Net (loss) income	0		0		0		(325,000)		(325,000)		19,000		(306,000)	—		—		—		(1,976,000)		(1,976,000)		17,000		(1,959,000)
Balance — March 31, 2022	23,027,978	$	23,000	$	116,409,000	$	(85,366,000)	$	31,066,000	$	172,000	$	31,238,000
Balance — March 31, 2023														23,027,978	$	23,000	$	116,439,000	$	(95,710,000)	$	20,752,000	$	177,000	$	20,929,000
Stock-based compensation	0		0		6,000		0		6,000		0		6,000	—		—		10,000		—		10,000		—		10,000
Distributions paid to noncontrolling interests	0		0		0		0		0		(18,000)		(18,000)	—		—		—		—		—		(19,000)		(19,000)
Net (loss) income	0		0		0		(2,194,000)		(2,194,000)		18,000		(2,176,000)	—		—		—		(1,681,000)		(1,681,000)		19,000		(1,662,000)
Balance — June 30, 2022	23,027,978	$	23,000	$	116,415,000	$	(87,560,000)	$	28,878,000	$	172,000	$	29,050,000
Balance — June 30, 2023														23,027,978	$	23,000	$	116,449,000	$	(97,391,000)	$	19,081,000	$	177,000	$	19,258,000


	Common Stock													Common Stock
		Common													Common
	Number	Stock		Additional				Total						Number	Stock		Additional				Total
	of	Par		Paid-In		Accumulated		Stockholders’		Noncontrolling		Total		of	Par		Paid-In		Accumulated		Stockholders’		Noncontrolling		Total
	Shares	Value		Capital		Deficit		Equity		Interests		Equity		Shares	Value		Capital		Deficit		Equity		Interests		Equity
Balance — January 1, 2021	23,027,978	$	23,000	$	116,335,000	$	(84,456,000)	$	31,902,000	$	195,000	$	32,097,000
Balance — January 1, 2022														23,027,978	$	23,000	$	116,401,000	$	(85,041,000)	$	31,383,000	$	171,000	$	31,554,000
Stock-based compensation	0		0		36,000		0		36,000		0		36,000	—		—		8,000		—		8,000		—		8,000
Distributions paid to noncontrolling interests	0		0		0		0		0		(16,000)		(16,000)	—		—		—		—		—		(18,000)		(18,000)
Net (loss) income	0		0		0		(1,758,000)		(1,758,000)		18,000		(1,740,000)	—		—		—		(325,000)		(325,000)		19,000		(306,000)
Balance — March 31, 2021	23,027,978	$	23,000	$	116,371,000	$	(86,214,000)	$	30,180,000	$	197,000	$	30,377,000
Balance — March 31, 2022														23,027,978	$	23,000	$	116,409,000	$	(85,366,000)	$	31,066,000	$	172,000	$	31,238,000
Stock-based compensation	0		0		11,000		0		11,000		0		11,000	—		—		6,000		—		6,000		—		6,000
Distributions paid to noncontrolling interests	0		0		0		0		0		(19,000)		(19,000)	—		—		—		—		—		(18,000)		(18,000)
Net income (loss)	0		0		0		2,551,000		2,551,000		22,000		2,573,000
Balance — June 30, 2021	23,027,978	$	23,000	$	116,382,000	$	(83,663,000)	$	32,742,000	$	200,000	$	32,942,000
Net (loss) income														—		—		—		(2,194,000)		(2,194,000)		18,000		(2,176,000)
Balance — June 30, 2022														23,027,978	$	23,000	$	116,415,000	$	(87,560,000)	$	28,878,000	$	172,000	$	29,050,000

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Table of Contents

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Six Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2023		2022
Cash flows from operating activities:
Net (loss) income	$	(2,482,000)	$	833,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Net loss					$	(3,621,000)	$	(2,482,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of debt issuance costs		457,000		34,000		457,000		457,000
Depreciation and amortization		3,685,000		792,000		3,615,000		3,685,000
Amortization of above-market lease intangible		32,000		—		32,000		32,000
Straight-line rents		(748,000)		494,000		(606,000)		(748,000)
Stock-based compensation expense		14,000		47,000		17,000		14,000
Gain on sale of equity-method investment		—		(3,515,000)
Loss from equity-method investees		489,000		785,000
(Income) loss from equity-method investees						(242,000)		489,000
Change in operating assets and liabilities:
Tenant and other receivables, net		202,000		501,000		279,000		202,000
Other assets		(261,000)		275,000
Other assets, net						15,000		(261,000)
Accounts payable and accrued liabilities		2,387,000		83,000		768,000		2,387,000
Net cash provided by operating activities		3,775,000		329,000		714,000		3,775,000

Cash flows from investing activities:
Additions to real estate		(132,000)		—
Additions to real estate and other assets						(170,000)		(132,000)
Investment in equity-method investees		(722,000)		(123,000)		(156,000)		(722,000)
Proceeds from sale of equity-method investment		—		5,411,000
Distributions received from equity-method investees		272,000		1,250,000		203,000		272,000
Payments from notes receivable		—		123,000
Net cash (used in) provided by investing activities		(582,000)		6,661,000
Net cash used in investing activities						(123,000)		(582,000)

Cash flows from financing activities:
Payments of loans payable		(551,000)		(518,000)		(572,000)		(551,000)
Distributions paid to noncontrolling interests		(36,000)		(35,000)		(36,000)		(36,000)
Deferred financing costs						(86,000)		—
Net cash used in financing activities		(587,000)		(553,000)		(694,000)		(587,000)

Net increase in cash, cash equivalents and restricted cash		2,606,000		6,437,000
Net (decrease) increase in cash, cash equivalents and restricted cash						(103,000)		2,606,000
Cash, cash equivalents and restricted cash – beginning of period		13,161,000		17,591,000		14,163,000		13,161,000
Cash, cash equivalents and restricted cash – end of period	$	15,767,000	$	24,028,000	$	14,060,000	$	15,767,000

Supplemental disclosure of cash flow information:
Cash paid for interest	$	4,809,000	$	816,000	$	7,789,000	$	4,809,000

Supplemental disclosure of non-cash investing activities:
Additions to real estate included in accounts payable and accrued liabilities	$	112,000	$	0

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

Table of Contents

SUMMIT HEALTHCARE REIT, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, ~~2022~~2023

(Unaudited)

1. Organization

Summit Healthcare REIT, Inc. (“Summit”) is a real estate investment trust that owns 100% of 14 properties, 95.3% of four properties, a 10% equity interest in an unconsolidated equity-method investment that holds 17 properties, a 35% equity interest in an unconsolidated equity-method investment that holds 1one property, a 20% equity interest in an unconsolidated equity-method investment that holds 2two properties, a 10% equity interest in an unconsolidated equity-method investment that holds 9nine properties, and a 10% equity interest in an unconsolidated equity-method investment that holds six properties. In June 2021, we sold our 15% equity interest in an unconsolidated equity-method investment that held 14 properties. Summit is a Maryland corporation, formed in 2004 under the General Corporation Law of Maryland for the purpose of investing in and owning real estate. As used in these notes, the “Company”, “we”, “us” and “our” refer to Summit and its consolidated subsidiaries, including but not limited to Summit Healthcare Operating Partnership, L.P. (the “Operating Partnership”), except where the context otherwise requires.

We conduct substantially all of our operations through the Operating Partnership, which is a Delaware limited partnership. We own a 99.88% general partner interest in the Operating Partnership, and Cornerstone Realty Advisors, LLC (“CRA”), a former affiliate, owns a 0.12% limited partnership interest.

Summit and the Operating Partnership are managed and operated as one entity, and Summit has no significant assets other than its investment in the Operating Partnership. Summit, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership. ~~Therefore, the assets and liabilities of Summit and the Operating Partnership are the same.~~

Cornerstone Healthcare Partners LLC – Consolidated Joint Venture

We own 95% of Cornerstone Healthcare Partners LLC (“CHP LLC”), which was formed in 2012, and the remaining 5% noncontrolling interest is owned by Cornerstone Healthcare Real Estate Fund, Inc. (“CHREF”), an affiliate of CRA. CHP LLC is consolidated within our condensed consolidated financial statements and owns 4four properties (the “JV Properties”) with another partially owned subsidiary. As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, we own a 95.3% interest in the 4four JV Properties, and CHREF owns a 4.7% interest.

Summit Union Life Holdings, LLC – Equity-Method Investment

In April 2015, through our Operating Partnership, we entered into a limited liability company agreement with Best Years, LLC (“Best Years”), an unrelated entity and a U.S.-based affiliate of Union Life Insurance Co, Ltd. (a Chinese corporation), and formed Summit Union Life Holdings, LLC (the “SUL JV”). The SUL JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, we have a 10% interest in the SUL JV which owns 17 properties.

Summit Fantasia Holdings, LLC – Equity-Method Investment

In September 2016, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia Investment III LLC (“Fantasia”), an unrelated entity and a U.S.-based affiliate of Fantasia Holdings Group Co., Limited (a Chinese corporation listed on the Stock Exchange of Hong Kong (HKEX)), and formed Summit Fantasia Holdings, LLC (the “Fantasia I JV”). The Fantasia I JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, we have a 35% interest in the Fantasia I JV which owns ~~1 property at June 30, 2022 and owned 2 properties at December 31, 2021.~~one property.

~~Table of Contents~~

Summit Fantasia Holdings II, LLC – Equity-Method Investment

In December 2016, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia, and formed Summit Fantasia Holdings II, LLC (the “Fantasia II JV”). The Fantasia II JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, we have a 20% interest in the Fantasia II JV which owns 2two properties.

Table of Contents

Summit Fantasia Holdings III, LLC– Equity-Method Investment

In July 2017, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia and formed Summit Fantasia Holdings III, LLC (the “Fantasia III JV”). The Fantasia III JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, we have a 10% interest in the Fantasia III JV which owns 9nine properties.

Summit Fantasy Pearl Holdings, LLC– Equity-Method Investment

In October 2017, through our Operating Partnership, we entered into a limited liability company agreement with Fantasia, Atlantis Senior Living 9, LLC, a Delaware limited liability company (“Atlantis”), and Fantasy Pearl LLC, a Delaware limited liability company (“Fantasy”), and formed Summit Fantasy Pearl Holdings, LLC (the “FPH JV”). The FPH JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements. As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, we have a 10% interest in the FPH JV which owns 6six properties.

~~Indiana JV– Equity-Method Investment~~Taxable REIT Subsidiaries

~~In June 2021, we sold our 15% equity interest in the Indiana joint venture (the “Indiana JV”) for approximately $5.4 million. See Note 5 for further information.~~

~~As of June 30, 2022 and December 31, 2021, we have a 0% interest in the Indiana JV.~~

Summit Healthcare Asset Management, LLC ~~(TRS)~~

Summit Healthcare Asset Management, LLC (“SAM TRS”) is our wholly-owned taxable REIT subsidiary (“TRS”). We serve as the manager of the SUL JV, Fantasia I JV, Fantasia II JV, Fantasia III JV, and FPH JV ~~and the Indiana JV prior to the sale of our equity interest on June 11, 2021~~ (collectively, our “Equity-Method Investments”), and provide management services in exchange for fees and reimbursements. All asset management fees earned by us are paid to SAM TRS and expenses incurred by us, as the manager, are reimbursed from SAM TRS. See Notes 5 and 7 for further information.

SHOP TRS LLC

SHOP TRS LLC (“SHOP TRS”) is our wholly-owned taxable REIT subsidiary that is the sole member for two of our 100% owned real estate properties that are leased to an affiliated subsidiary (see Note 3 under Pennington Gardens Operations LLC (“Pennington Gardens”) and Sundial Operations LLC (“Sundial Assisted Living”), collectively, the “Operated Properties”) and the operations are consolidated in our condensed consolidated financial statements.

Coronavirus (COVID-19)

The world was, and continues to be, impacted by the COVID-19 pandemic. The healthcare industry was among those most adversely affected by the COVID-19 pandemic. In 2022, two of our tenants experienced a material adverse effect on their operations related to COVID-19, which affected their ability to make rent payments in 2022 and resulted in the termination of the leases and becoming Operated Properties (see Note 3 for further information). Additionally, see Note 5 for further discussion related to our Equity-Method Investments.

The extent to which COVID-19 could continue to impact our business, cash flow and results of operations is highly uncertain and cannot be predicted with confidence. The fluidity of this situation precludes any prediction as to the ultimate material adverse impact on the demand for senior housing and skilled nursing and presents material uncertainty and risk with respect to our business, operations, financial condition and liquidity, including recording impairments, lease modifications and credit losses in future periods.

2. Summary of Significant Accounting Policies

For more information regarding our significant accounting policies and estimates, please refer to “Summary of Significant Accounting Policies” contained in the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 filed with the Securities and Exchange Commission (“SEC”) on March 31, ~~2022. In addition, refer to our revenue recognition note below related to our resident fees and services.~~2023.

Table of Contents

The accompanying condensed consolidated balance sheet at December 31, ~~2021~~2022 has been derived from the audited consolidated financial statements at that date. We assume that users of these condensed consolidated financial statements have read or have access to the audited December 31, ~~2021~~2022 consolidated financial statements and contained in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 filed with the SEC on March 31, ~~2022~~2023 and that the adequacy of additional disclosure needed for a fair presentation, except in regard to material contingencies, may be determined in that context. Accordingly, footnotes and other disclosures which would substantially duplicate those contained in our most recent Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 have been omitted in this report.

~~Table of Contents~~

Principles of Consolidation and Basis of Presentation

The accompanying condensed consolidated financial statements include the accounts of the Company, its wholly-owned subsidiaries, the Operating Partnership and its consolidated companies and are prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). All intercompany accounts and transactions have been eliminated in consolidation.

The accompanying financial information reflects all adjustments, which are, in the opinion of management, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year. Operating results for the three and six months ended June 30, ~~2022~~2023 are not necessarily indicative of the results that may be expected for the year ending December 31, ~~2022.~~2023.

Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown on the condensed consolidated statements of cash flows.

June 30,

December 31,

2022

2021
Cash and cash equivalents

$
13,067,000

$
10,488,000
Restricted cash

2,700,000

2,673,000
Total cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows

$
15,767,000

$
13,161,000

~~Coronavirus (COVID-19)~~

The world was, and continues to be, impacted by the COVID-19 pandemic. The healthcare industry was among those most adversely affected by the COVID-19 pandemic. Two of our tenants have experienced a material adverse effect on their operations related to COVID-19, which has affected their ability to make rent payments in 2022 and 2021 (see Note 3 for further information on its impact on us).

The extent to which COVID-19 could continue to impact our business, cash flow and results of operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the rate of public acceptance and usage of vaccines and the effectiveness of vaccines in limiting the spread of COVID-19 and its variants, resurgences of COVID-19 and, in particular, new and more contagious and/or vaccine resistant variants, actions taken to contain the spread of COVID-19 and how quickly and to what extent normal economic and operating conditions can resume. The fluidity of this situation precludes any prediction as to the ultimate material adverse impact on the demand for senior housing and skilled nursing and presents material uncertainty and risk with respect to our business, operations, financial condition and liquidity, including recording impairments, lease modifications and credit losses in future periods.

~~Reclassification of Intangible Lease Assets~~

~~The following table provides a reconciliation for the reclassification of our intangible lease assets as of December 31, 2021 in our consolidatedbalance sheets to conform to the presentation as of June 30, 2022:~~

As previously reported

Increase (decrease)

As reclassified
Real estate assets, net

$
192,862,000

$
(13,760,000)

$
179,102,000
Intangible lease assets, net

$
—

$
14,687,000

$
14,687,000
Other assets, net

$
1,349,000

$
(927,000)

$
422,000
Total assets

$
219,126,000

$
—

$
219,126,000

The intangible lease assets related to our prior acquisitions in 2021 were reclassified from real estate properties, net and other assets, net into a separate line item as of June 30, 2022. The result of this reclassification did not have any effect on our total assets, liabilities, accumulated deficit, net loss or statements of cash flows.

~~Table of Contents~~

~~Revenue Recognition - Resident Fees and Services~~

We recognize resident fees and services revenue at the amount that we expect to be entitled to in exchange for providing resident care and services. Resident fees are recognized and billed monthly based on the contracted rate in the resident lease agreements and the reimbursements from Medicaid are based on contracted reimbursement rates. These amounts are paid directly from the residents and/or third-party payors (currently only Medicaid). Revenue is recognized as performance obligations are satisfied. Performance obligations are determined based on the nature of the services provided by us. The majority of resident fees and services is attributable to the portion of the base monthly lease fee in the resident lease agreement. The Company has elected the lessor practical expedient within ASC 842, Leases (“ASC 842”) and recognizes the resident fee revenue based upon the predominant component, either the lease or non-lease component, of the contracts. The Company has determined that the lease component is the predominant component and the services included under the resident agreements have the same timing and pattern of transfer and are performance obligations that are satisfied over time. Resident services consist of care level services and certain other ancillary services (i.e., housekeeping, laundry, etc.). These services are provided and paid for in addition to the standard fees included in each resident lease (i.e., room and board, standard meals, etc.).

Laws and regulations concerning government programs, including Medicare and Medicaid, are complex and subject to varying interpretation. As a result of investigations by governmental agencies, various healthcare organizations have received requests for information and notices regarding alleged noncompliance with those laws and regulations, which, in some instances, have resulted in organizations entering into significant settlement agreements. Compliance with such laws and regulations may also be subject to future government review and interpretation as well as significant regulatory action, including fines, penalties and potential exclusion from the related programs. There can be no assurance that regulatory authorities will not challenge our compliance with these laws and regulations, and it is not possible to determine the impact (if any) such claims or penalties would have upon us.

Settlements with third-party payors for retroactive adjustments due to audits, reviews or investigations are considered variable consideration and are included in the determination of the estimated transaction price for providing patient care. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and our historical settlement activity, including an assessment to ensure that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the retroactive adjustment is subsequently resolved. Estimated settlements are adjusted in future periods as adjustments become known (that is, new information becomes available), or as years are settled or are no longer subject to such audits, reviews and investigation.


	June 30,		December 31,
	2023		2022
Cash and cash equivalents	$	11,138,000	$	11,572,000
Restricted cash		2,922,000		2,591,000
Total cash, cash equivalents, and restricted cash shown on the condensed consolidated statements of cash flows	$	14,060,000	$	14,163,000

3. Investments in Real Estate Properties

As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, our investments in real estate properties, including those held by our consolidated subsidiaries (excluding the 35 properties owned by our unconsolidated Equity-Method Investments), are set forth below:


	June 30,		December 31,		June 30,		December 31,
	2022		2021		2023		2022
Land	$	15,565,000	$	15,565,000	$	15,565,000	$	15,565,000
Buildings and improvements		166,989,000		166,989,000		166,989,000		166,989,000
Less: accumulated depreciation		(13,694,000)		(11,395,000)		(18,264,000)		(15,985,000)
Buildings and improvements, net		153,295,000		155,594,000		148,725,000		151,004,000
Furniture and fixtures		12,381,000		12,137,000		12,570,000		12,440,000
Less: accumulated depreciation		(5,060,000)		(4,194,000)		(6,702,000)		(5,882,000)
Furniture and fixtures, net		7,321,000		7,943,000		5,868,000		6,558,000
Real estate properties, net	$	176,181,000	$	179,102,000	$	170,158,000	$	173,127,000

For the three months ended June 30, 2023 and 2022, ~~and 2021,~~ depreciation ~~and amortization~~ expense (excluding ~~intangible~~ lease intangibles amortization and leasing commission amortization) was approximately $1.6 million and ~~$0.4~~$1.6 million, respectively. For the six months ended June 30, ~~2022~~2023 and ~~2021,~~2022, depreciation expense (excluding intangible lease amortization and leasing commission amortization) was approximately ~~$3.2~~$3.1 million and ~~$0.8~~$3.2 million, respectively.

As of June 30, ~~2022,~~2023, our portfolio consisted of 18 real estate properties, 16 of which were 100% leased to the tenants of the related facilities. The other two properties are each 100% leased to an affiliated subsidiary (see below under Pennington Gardens Operations LLC and Sundial Operations LLC).

~~Table of Contents~~

During 2021, our tenants for the Pennington Gardens and Sundial Assisted Living facilities experienced a material adverse effect on their operations related to COVID-19 and other operator issues that affected their ability to make their rent payments in 2022 and 2021. As a result, we experienced the following impacts:

~~Pennington Gardens Operations LLC~~

In March 2021, under a receivership, we began recording rent payments on a cash basis for our Pennington Gardens facility and wrote off the remaining straight-line rent receivable of $0.4 million. In October 2021, we reached an agreement with the tenant to terminate the lease. We notified the lender and the U.S. Department of Housing and Urban Development (“HUD”) and requested emergency approval to change the operator and terminate the lease.

On February 3, 2022, the current receiver, who was acting as the operator, received the license to be the licensed operator. As such, on February 10, 2022, the tenant’s lease was terminated, and we received $0.2 million from the tenant as part of the settlement agreement which was recorded in total rental revenues in the condensed consolidated statements of operations for the six months ended June 30, 2022. Concurrently, we entered into a new lease agreement with Pennington Gardens Operations LLC, the newly formed operating company for Pennington Gardens, which is a wholly owned subsidiary of SHOP TRS LLC, a recently formed wholly-owned taxable REIT subsidiary of Summit. As such, the operations of Pennington Gardens are consolidated in our financial statements beginning February 11, 2022, and all intercompany transactions have been eliminated. For the three and six months ended June 30, 2022, revenues from Pennington Gardens Operations are recorded under resident fees and services and costs are recorded under resident costs in the condensed consolidated statements of operations.

~~Sundial Operations LLC~~

In October 2021, we reached an agreement with the tenant of our Sundial Assisted Living facility in Redding, California to terminate the lease, and we have requested approval from HUD to terminate the lease and install a new licensed operator/manager. Beginning in June 2021, we recorded rent payments on a cash basis and in May 2021, wrote off the remaining straight-line rent receivable of $0.1 million.

On June 6, 2022, the new operator received approval to be the licensed operator of the facility and the previous tenant’s lease was terminated. We received $0.05 million from the tenant as part of the settlement agreement, which was recorded in total rental revenues in the condensed consolidated statements of operations for the three and six months ended June 30, 2022. On June 7, 2022, we entered into a new lease agreement with Sundial Operations LLC, the newly formed operating company for Sundial Assisted Living, which is a wholly owned subsidiary of SHOP TRS LLC. As such, the operations of Sundial Assisted Living will be consolidated in our financial statements as of June 7, 2022. For the three and six months ended June 30, 2022, revenues from Sundial Operations are recorded under resident fees and services and costs are recorded under resident costs in the condensed consolidated statements of operations.

119

Table of Contents

During 2022, our tenants for the Pennington Gardens and Sundial Assisted Living facilities experienced a material adverse effect on their operations related to COVID-19 and other operator issues that affected their ability to make their rent payments in 2022. As a result, we experienced the following impacts:

Pennington Gardens Operations LLC

In February 2022, our former tenant’s lease was terminated and we received approximately $0.2 million under a settlement agreement which is recorded in total rental revenues in the condensed consolidated statements of operations. Concurrently, we entered into a management agreement with a new operator that began operating the facility, Pennington Gardens and we entered into a new lease agreement with Pennington Gardens Operations LLC, the newly formed operating company for Pennington Gardens, which is a wholly owned subsidiary of SHOP TRS. As such, the operations of Pennington Gardens are consolidated in our financial statements beginning February 11, 2022, and all intercompany transactions have been eliminated. For the three and six months ended June 30, 2023 and for the period from February 11, 2022 through June 30, 2022, revenues from Pennington Gardens Operations are recorded under resident fees and services and costs are recorded under resident costs in the condensed consolidated statements of operations.

Sundial Operations LLC

In June 2022, our former tenant’s lease was terminated and we entered into a management agreement with a new operator that began operating the facility, Sundial Assisted Living. Concurrently, we entered into a new lease agreement with Sundial Operations LLC, the newly formed operating company for Sundial Assisted Living, which is a wholly owned subsidiary of SHOP TRS. As such, for the three and six months ended June 30, 2023 and for the period from June 7, 2022 through June 30, 2022, the operations of Sundial Assisted Living are consolidated in our financial statements and revenues from Sundial Assisted Living are recorded under resident fees and services and costs are recorded under resident costs in the condensed consolidated statements of operations.

The following table provides summary information regarding our portfolio (excluding the 35 properties owned by our unconsolidated Equity-Method Investments and the $12.75 million loan from Oxford Finance, LLC (“Oxford”) (see Note 4) with Summit Georgia Holdings LLC, our wholly-owned subsidiary) as of June 30, ~~2022:~~2023:

Loans

Payable,

Excluding

Debt

Purchase

Issuance

Purchase

Issuance

Property

Location

Date Purchased

Type⁽¹⁾

Price

Costs

Location

Date Purchased

Type⁽¹⁾

Price

Costs

Sheridan Care Center

Sheridan, OR

August 3, 2012

SNF

4,100,000

4,087,000

Sheridan, OR

August 3, 2012

SNF

4,100,000

3,916,000

Fernhill Care Center

Portland, OR

August 3, 2012

SNF

4,500,000

3,585,000

Portland, OR

August 3, 2012

SNF

4,500,000

3,435,000

Friendship Haven Healthcare and Rehabilitation Center

Galveston County, TX

September 14, 2012

SNF

15,000,000

11,434,000

Galveston County, TX

September 14, 2012

SNF

15,000,000

11,219,000

Pacific Health and Rehabilitation Center

Tigard, OR

December 24, 2012

SNF

8,140,000

5,976,000

Tigard, OR

December 24, 2012

SNF

8,140,000

5,727,000

Brookstone of Aledo

Aledo, IL

July 2, 2013

8,625,000

6,666,000

Aledo, IL

July 2, 2013

8,625,000

6,531,000

Sundial Assisted Living⁽²⁾

Redding, CA

December 18, 2013

3,500,000

3,712,000

Redding, CA

December 18, 2013

3,500,000

3,655,000

Pennington Gardens ⁽²⁾

Chandler, AZ

July 17, 2017

AL/MC

13,400,000

10,117,000

Chandler, AZ

July 17, 2017

AL/MC

13,400,000

9,960,000

Yucaipa Hill Post Acute

Yucaipa, CA

July 2, 2021

SNF

10,715,000

8,014,000

Yucaipa, CA

July 2, 2021

SNF

10,715,000

8,014,000

Creekside Post Acute

Yucaipa, CA

July 2, 2021

SNF

4,780,000

3,575,000

Yucaipa, CA

July 2, 2021

SNF

4,780,000

3,575,000

University Post Acute

Mentone, CA

July 2, 2021

SNF

4,560,000

3,411,000

Mentone, CA

July 2, 2021

SNF

4,560,000

3,411,000

Calhoun Health Center

Calhoun, GA

December 30, 2021

SNF

7,670,000

6,549,000

Calhoun, GA

December 30, 2021

SNF

7,670,000

6,549,000

Maple Ridge Health Care Center

Cartersville, GA

December 30, 2021

SNF

13,548,000

11,568,000

Cartersville, GA

December 30, 2021

SNF

13,548,000

11,568,000

Chatsworth Health Care Center

Chatsworth, GA

December 30, 2021

SNF

29,785,000

25,432,000

Chatsworth, GA

December 30, 2021

SNF

29,785,000

25,432,000

East Lake Arbor

Decatur, GA

December 30, 2021

SNF

15,640,000

13,354,000

Decatur, GA

December 30, 2021

SNF

15,640,000

13,354,000

Fairburn Health Care Center

Fairburn, GA

December 30, 2021

SNF

14,644,000

12,503,000

Fairburn, GA

December 30, 2021

SNF

14,644,000

12,503,000

Grandview Health Care Center

Jasper, GA

December 30, 2021

SNF

10,061,000

8,591,000

Jasper, GA

December 30, 2021

SNF

10,061,000

8,591,000

Rosemont at Stone Mountain

Stone Mountain, GA

December 30, 2021

SNF

23,908,000

20,414,000

Stone Mountain, GA

December 30, 2021

SNF

23,908,000

20,414,000

Willowwood Nursing Center & Rehab

Flowery Branch, GA

December 30, 2021

SNF

14,744,000

12,589,000

Flowery Branch, GA

December 30, 2021

SNF

14,744,000

12,589,000

Total:

207,320,000

171,577,000

207,320,000

170,443,000

(1)	SNF is an abbreviation for skilled nursing facility.

AL is an abbreviation for assisted living facility.

MC is an abbreviation for memory care facility.

~~(2)~~Table of Contents~~See above under Pennington Gardens Operations LLC and Sundial Operations LLC.~~

Future Minimum Lease Payments

The future minimum lease payments to be received under our existing tenant operating leases (excluding the 35 properties owned by our unconsolidated Equity-Method Investments and the intercompany ~~leases~~lease between our wholly-owned ~~subsidiaries,~~subsidiaries: Summit Chandler LLC and Pennington Gardens, ~~Operations LLC,~~and HP Redding LLC and ~~Sundial Operations LLC)~~Sundial) as of June 30, ~~2022,~~2023, for the period from July 1, ~~2022~~2023 to December 31, ~~2022~~2023 and for each of the four following years and thereafter ending December 31 are as follows:


Years ending
July 1, 2022 to December 31, 2022	$	8,864,000
2023		17,983,000
July 1, 2023 to December 31, 2023			$	9,006,000
2024		18,272,000		18,272,000
2025		18,566,000		18,566,000
2026		18,865,000		18,865,000
2027				19,168,000
Thereafter		165,462,000		146,294,000
	$	248,012,000	$	230,171,000

~~2022~~2023 Acquisitions

None.

122022 Acquisitions

None.

~~Table~~Impairment of ~~Contents~~

~~2021 Acquisitions~~

~~CA3~~Real Estate Properties

On July 2, 2021, through our wholly-owned subsidiary, we acquired 3 skilled nursing facilities, 2 located in Yucaipa, California and 1 located in Mentone, California (collectively, the “CA3 Properties”), for the purchase price of $20,055,000, which was funded through cash on hand plus the proceeds from the loan described in Note 4. We incurred approximately $80,000 in acquisition costs in connection with these acquisitions. The CA3 Properties are leased to 3 tenants under three separate 15-year triple net leases, each of which ~~has~~ ~~two five-year renewal options.~~

~~GA8 Properties~~

On December 30, 2021, through Summit Georgia Holdings LLC, our wholly-owned subsidiary, we acquired 8 skilled nursing facilities located in Georgia (collectively, the “GA8 Properties”), for the total purchase price of $130,000,000, which was funded through cash on hand plus the proceeds from the loans described in Note 4. The GA8 Properties are leased to eight tenants under eight separate 15-year triple net leases, each of which has ~~two~~ ~~five-year renewal options.~~

~~Leasing Commissions~~

As a ~~self-managed REIT,~~result of our ongoing analysis for potential impairment of our investments in real estate, we ~~have not paid leasing commissions since 2013. Leasing commissions are capitalized at cost and amortized on a straight-line basis over~~may be required to adjust the ~~related lease term. As~~carrying value of June 30, 2022 and December 31, 2021, the unamortized balance of capitalized leasing commissions was approximately $0.4 million and $0.5 million, respectively. Amortization expense for the three months ended June 30, 2022 and 2021 was approximately $31,000 and $18,000, respectively. Amortization expense forcertain assets to their estimated fair values, or estimated fair value less selling costs, under certain circumstances. No impairments were recorded during the six months ended June 30, ~~2022 and 2021 was approximately $48,000 and $35,000, respectively.~~2023 or 2022.

1311

Table of Contents

4. Loans Payable

As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, our loans payable consisted of the following:


	June 30, 2022		December 31, 2021		June 30, 2023		December 31, 2022
Loans payable to Lument (formerly ORIX Real Estate Capital, LLC) (insured by HUD) in monthly installments of approximately $183,000, including interest, ranging from a fixed rate of 2.79% to 4.2%, due in September 2039 through April 2055, and as of June 30, 2022 and December 31, 2021, collateralized by Sheridan, Fernhill, Pacific Health, Aledo, Sundial and Friendship Haven.	$	35,460,000	$	35,934,000
Loans payable to Lument (formerly ORIX Real Estate Capital, LLC) (insured by HUD) in monthly installments of approximately $183,000, including interest, ranging from a fixed rate of 2.79% to 4.2%, due in September 2039 through April 2055, and as of June 30, 2023 and December 31, 2022, collateralized by Sheridan, Fernhill, Pacific Health, Aledo, Sundial and Friendship Haven.					$	34,484,000	$	34,976,000

Loan payable to Capital One Multifamily Finance, LLC (insured by HUD) in monthly installments of approximately $49,000, including interest at a fixed rate of 4.23%, due in September 2053, and collateralized by Pennington Gardens.		10,117,000		10,194,000		9,959,000		10,039,000

Loan payable to CIBC Bank, USA in monthly installments of approximately of $65,000 interest only through July 2022 at LIBOR (with a floor of 1%) plus 4% (5.12% and 5% at June 30, 2022 and December 31, 2021, respectively), due in July 2024, and as of December 31, 2021, collateralized by Yucaipa Hill Post Acute, Creekside Post Acute and University Post Acute.		15,000,000		15,000,000
Loan payable to CIBC Bank, USA in monthly installments of approximately of $133,000 including cash collateral fund payments, variable interest rate (9.3% and 8.2% at June 30, 2023 and December 31, 2022, respectively), due in July 2024, and as of December 31, 2022, collateralized by Yucaipa Hill Post Acute, Creekside Post Acute and University Post Acute (“CA3 Properties”).						15,000,000		15,000,000

Loan payable to CIBC Bank, USA in monthly installments of approximately $314,000 (interest only through December 2023) at SOFR plus 3.50% with a SOFR floor of 0.5%, (4.63% and 4% at June 30, 2022 and December 31, 2021, respectively), due in December 2024, and as of June 30, 2022 and December 31, 2021, collateralized by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab.		91,000,000		91,000,000
Loan payable to CIBC Bank, USA in monthly installments of approximately $600,000 (interest only through December 2023) variable interest rate (8.7% and 7.7% at June 30, 2023 and December 31, 2022, respectively), due in December 2024, and collateralized by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab (“GA8 Properties”).						91,000,000		91,000,000

Loan payable to Oxford Finance, LLC in monthly installments of approximately $207,000 (interest only through maturity), at LIBOR (with a floor of 1%) plus 11% (12.12% and 12% at June 30, 2022 and December 31, 2021, respectively) due in March 2025, collateralized in second position by Calhoun Health Center, Maple Ridge Health Care Center, Chatsworth Health Care Center, East Lake Arbor, Fairburn Health Care Center, Grandview Health Care Center, Rosemont at Stone Mountain, and Willowwood Nursing Center & Rehab.		20,000,000		20,000,000
Loan payable to Oxford Finance, LLC in monthly installments of approximately $260,000 (interest only through maturity), variable interest rate (16.2% and 15.1% at June 30, 2023 and December 31, 2022, respectively) due in March 2025, collateralized in second position by the GA8 Properties.						20,000,000		20,000,000

Mezzanine Loan payable to Oxford Finance, LLC in monthly installments of approximately $132,000 (interest only through maturity), at LIBOR (with a floor of 1%) plus 11% (12.12% and 12% at June 30, 2022 and December 31, 2021, respectively) due in December 2026, secured by the equity interests of our wholly-owned subsidiary, Summit Georgia Holdings LLC, the parent holding company for the GA8 Properties.		12,750,000		12,750,000
Mezzanine Loan payable to Oxford Finance, LLC in monthly installments of approximately $168,000 (interest only through maturity), variable interest rate (16.2% and 15.1% at June 30, 2023 and December 31, 2022, respectively) due in December 2026, secured by the equity interests of our wholly-owned subsidiary, Summit Georgia Holdings LLC, the parent holding company for the GA8 Properties.						12,750,000		12,750,000
		184,327,000		184,878,000		183,193,000		183,765,000
Less debt issuance costs		(4,051,000)		(4,508,000)		(3,139,000)		(3,596,000)
Total loans payable	$	180,276,000	$	180,370,000	$	180,054,000	$	180,169,000

As of June 30, ~~2022,~~2023, we have total debt obligations of approximately ~~$184.3~~$183.2 million that will mature between 2024 and 2055. See Note 3 for loans payable balance for each property. All of the loans payable have certain financial and non-financial covenants, including ratios and financial statement considerations. As of June 30, ~~2022,~~2023, we were in compliance with all of our debt ~~covenants.~~covenants except for our GA8 Properties which were out of compliance with their consolidated minimum EBITDAR covenant. We have requested a waiver.

During the three months ended June 30, ~~2022~~2023 and ~~2021,~~2022, we incurred approximately ~~$2.7~~$4.1 million and ~~$0.5~~$2.7 million of interest expense, respectively, ~~(excluding~~excluding debt issuance costs, amortization and interest expense related to the Oxford mezzanine loan as noted below (“Oxford Monthly Fee”), related to our loans payable. During the six months ended June 30, ~~2022~~2023 and ~~2021,~~2022, we incurred approximately ~~$5.2~~$8.0 million and ~~$1.0~~$5.2 million, respectively, of interest expense (excluding debt issuance costs, ~~and~~ amortization and interest expense related to the Oxford ~~mezzanine loan as noted below (“Oxford~~ Monthly ~~Fee”))~~Fee) related to our loans payable.

1412

Table of Contents

In connection with our loans payable, we incurred debt issuance costs. As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the unamortized balance of the debt issuance costs was approximately ~~$4.1~~$3.1 million and ~~$4.5~~$3.6 million, respectively. These debt issuance costs are being amortized over the life of their respective financing agreements using the straight-line basis which approximates the effective interest rate method. For each of the three months ended June 30, 2023 and 2022, ~~and 2021, $228,000 and $16,000, respectively,~~$0.2 million of debt issuance costs were amortized and included in interest expense in our condensed consolidated statements of operations. For each of the six months ended June 30, 2023 and 2022, ~~and 2021, $457,000 and $34,000, respectively,~~$0.5 million of debt issuance costs were amortized and included in interest expense in our condensed consolidated statements of operations.

During the three months ended June 30, 2023 and 2022, we incurred approximately $0 million and $0.2 million, respectively, of interest expense related to the Oxford Monthly Fee which is included in interest expense in our condensed consolidated statements of operations. During the six months ended June 30, 2023 and 2022, we incurred approximately $0 million and $0.4 million, respectively of interest expense related to the Oxford Monthly Fee and is included in interest expense in our condensed consolidated statements of operations.

The principal payments due on the loans payable (excluding debt issuance costs) for the period from July 1, ~~2022~~2023 to December 31, ~~2022~~2023 and for each of the four following years and thereafter ending December 31 are as follows:


	Principal		Principal
Years Ending	Amount		Amount
July 1, 2022 to December 31, 2022	$	718,000
2023		1,475,000
July 1, 2023 to December 31, 2023			$	584,000
2024		106,731,000		107,201,000
2025		21,246,000		21,246,000
2026		14,042,000		14,042,000
2027				1,341,000
Thereafter		40,115,000		38,779,000
	$	184,327,000	$	183,193,000

The following information notes our ~~recent~~ loan activity:

CA3 Properties

~~On July 2,~~In 2021, ~~in conjunction with the acquisition of the CA3 Properties (see Note 3),~~ we entered into a first priority $15.0 million mortgage loan collateralized by the CA3 Properties with CIBC Bank, USA (“CIBC”). The loan bears interest at the One Month London Interbank Offer Rate (“LIBOR”) (with a floor of 1%) plus 4.00%, or the Secured Overnight Financing Rate (“SOFR”) when LIBOR is discontinued, and matures on July 2, 2024. The loan is interest onlySee table above listing loans payable for the first year and thereafter requires additional monthly installments of principal that are held by the lender in a cash loan guarantee fund until maturity. The loan may be prepaid at any time with no penalty if the CA3 Properties are refinanced through HUD, otherwise we would be required to pay a prepayment premium equal to three percent (3%), two percent (2%) and one percent (1%) of the amount of the outstanding principal balance of the Loan prepaid if such prepayment occurs on or prior to the first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively. In the event the Company sells or transfers one or more properties, we would be required to pay an exit fee equal to (i) one-half of one percent (0.5%) of the amount of the outstanding principal balance of the Loan if such sale or transfer occurs on or prior to the second (2nd) year anniversary of the Closing Date; and (ii) zero percent (0%) if such sale or transfer occurs after the second (2nd) year anniversary of the Closing Date.futher information.

GA8 Properties

WeIn 2021, we acquired our interest in the GA8 Properties subject to a ~~$91~~$91.0 million first priority mortgage loan with CIBC collateralized by those properties, a ~~$20~~$20.0 million subordinated term loan with Oxford Financing LLC (“Oxford”) collateralized by those properties and a $12.75 million mezzanine loan with Oxford secured by the equity interests of the wholly-owned subsidiary, Summit Georgia Holdings LLC, the parent holding company for the GA8 Properties.

~~On December 30, 2021, we entered into a loan agreement with CIBC~~ See table above listing loans payable for $91.0 million in principal amount. The loan bears interest at the SOFR plus 3.50% with a SOFR floor of 50 basis points, or the bank’s base rate plus 0.75% (with a minimum of 4.0%), and matures on December 30, 2024. The loan is interest-only for two years and then requires additional monthly installments of principal that are held by the lender in a cash loan guarantee fund until maturity. The loan may be prepaid at any time with no penalty if the GA8 Properties are refinanced through HUD, otherwise we would be required to pay an a prepayment premium equal to three percent (3%), two percent (2%) and one percent (1%) of the amount of the outstanding principal balance of the Loan prepaid if such prepayment occurs on or prior

~~Table of Contents~~

to the first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively. In the event the Company sells or transfers one or more of the GA8 Properties, we would be required to pay an exit fee equal to (i) one-half of one percent (0.5%) of the amount of the outstanding principal balance of the Loan if such sale or transfer occurs on or prior to the second (2nd) year anniversary of the Closing Date; and (ii) zero percent (0%) if such sale or transfer occurs after the second (2nd) year anniversary of the Closing Date.

On December 30, 2021, we entered into a subordinated term loan agreement with Oxford for $20.0 million in principal amount. The loan bears interest at LIBOR plus 11.0% with a LIBOR floor of 100 basis points (or with a LIBOR replacement rate), and matures on June 30, 2025. The loan is interest only. The entire loan may be prepaid at any time and would be subject at that time to a prepayment premium fee equal to five percent (5%), two percent (2%) and one percent (1%) of the amount repaid if the repayment is made or the loan is accelerated prior to first (1st), second (2nd) and third (3rd) year anniversary of the closing date, respectively, or no prepayment fee if the GA8 Properties are refinanced through HUD. Additionally, we are required to pay an exit fee of $100,000 if the loan is paid off by December 31, 2024, or $140,000 if the loan is paid off after that date.

On December 30, 2021, we entered into a mezzanine loan agreement with Oxford for $12.75 million in principal amount. The loan bears interest at LIBOR plus 11.0% with a LIBOR floor of 100 basis points (or with a LIBOR replacement rate), and matures on December 30, 2026. The loan is interest-only and requires a monthly fee in the amount of (i) twenty-two percent (22%) of net cash flow attributable to each month or portion thereof during the loan term, and (ii) five percent (5%) of net cash flow attributable to each month or portion thereof during the post-repayment period which is the earlier of (i) the second anniversary of the loan repayment date and (ii) the date upon which Summit no longer owns any direct or indirect interest in any of the properties and all accrued monthly fees, all excess cash fees and all other liabilities then due agent or lenders are indefeasibly paid in full. The entire Oxford mezzanine loan may be prepaid at any time prior to the three-year anniversary and would be subject at that time to a yield maintenance premium fee equal to the interest that would have been paid for the full three years, which will be due and payable upon the earliest of the maturity or acceleration of the loan, or payment of the loan in full.futher information.

HUD-insured loans

We have six properties with HUD-insured loans from Lument Capital (formerly ORIX Real Estate Capital, LLC) and one property with a HUD-insured loan from Capital One Multifamily Finance, LLC. See table above listing loans payable for further information.

All of the HUD-insured loans are subject to customary representations, warranties and ongoing covenants and agreements with respect to the operation of the facilities, including the provision for certain maintenance and other reserve accounts for property tax, insurance, and capital expenditures, with respect to the facilities all as described in the HUD agreements. These reserves are included in restricted cash in our condensed consolidated balance sheets.

Table of Contents

5. Equity-Method Investments

As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the balances of our Equity-Method Investments were approximately ~~$7.5~~$5.2 million and ~~$7.9~~$5.2 million, respectively, and are as follows:

Summit Union Life Holdings, LLC

The SUL JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the SUL JV (the “SUL LLC Agreement”).

Under the SUL LLC Agreement, net operating cash flow of the SUL JV is distributed monthly, first to the Operating Partnership and Best Years pari passu up to a 9% to 10% annual return, ~~as defined,~~ and thereafter to Best Years 75% and the Operating Partnership 25%. All capital proceeds from the sale of the properties held by the SUL JV, a refinancing or another capital event will be paid first to the Operating Partnership and Best Years pari passu until each has received an amount equal to its accrued but unpaid 9% to 10% return plus its total contribution, and thereafter to Best Years 75% and the Operating Partnership 25%.

For the six months ended June 30, 2023 and 2022, we invested approximately $156,000 and $650,000, respectively, related to a capital ~~call~~calls for the SUL JV. During 2022, the SUL JV entered into agreements with brokers to market three properties for sale, however, no agreements for such sales have been executed.

As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the balance of our equity-method investment related to the SUL JV was approximately ~~$3.3~~$2.4 million and ~~$2.9~~$2.4 million, respectively.

~~Table of Contents~~

Summit Fantasia Holdings, LLC

The Fantasia I JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia JV (the “Fantasia I LLC Agreement”).

Under the Fantasia I LLC Agreement, net operating cash flow of the Fantasia I JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu until each member has received an amount equal to its accrued, but unpaid 8% return, and thereafter 50% to Fantasia and 50% to the Operating Partnership. All capital proceeds from the sale of the properties held by the Fantasia I JV, a refinancing or another capital event, will be paid first to the Operating Partnership and Fantasia pari passu until each has received an amount equal to its accrued but unpaid 8% return plus its total capital contribution, and thereafter 50% to Fantasia and 50% to the Operating Partnership.

For the six months ended June 30, 2023 and 2022, we invested approximately $0 and $72,000, respectively, related to a capital ~~call~~calls for the Fantasia I JV. In June 2022, the Fantasia I JV recorded an impairment charge of approximately $3.2 million and we recorded our 35% share of the impairment of approximately $1.1 million in loss from equity-method investees in the condensed consolidated statements of operations for the three and six months ended June 30, 2022. Additionally, we determined the fair value of our investment in the Fantasia I JV to be impaired and recorded a $0.1 million impairment charge which is recorded in the loss from equity-method investees in the condensed consolidated statements of operations for the three and six months ended June 30, 2022. In August 2022, the Fantasia I JV agreed to sell its remaining property, Sun Oak Assisted Living. In July 2023, Fantasia assigned their 65% interest, for no consideration, in the Fantasia I JV to Summit.

As of June 30, ~~2022~~2023 and December 31, ~~2021, the balance of~~2022, our equity-method investment related to the Fantasia I JV was ~~approximately $1.1 million and $2.0 million, respectively.~~$0.

Summit Fantasia Holdings II, LLC

The Fantasia II JV will exist until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia II JV (the “Fantasia II LLC Agreement”).

Table of Contents

Under the Fantasia II LLC Agreement, net operating cash flow of the Fantasia II JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu until each member has received an amount equal to its accrued, but unpaid 8% return, and thereafter 70% to Fantasia and 30% to the Operating Partnership. All capital proceeds from the sale of the properties held by the Fantasia II JV, a refinancing or another capital event, will be paid first to the Operating Partnership and Fantasia pari passu until each has received an amount equal to its accrued but unpaid 8% return plus its total capital contribution, and thereafter 70% to Fantasia and 30% to the Operating Partnership.

In June 2023, the tenant for the two properties in the Fantasia II JV filed for receivership. The two properties are currently being operated by the receivership estate in conjunction with a third party manager under a one-year management agreement. As of June 30, ~~2022~~2023, there has been no change in the tenant leases and the Fantasia II JV is currently negotiating with the receiver and manager regarding ongoing lease terms.

As of June 30, 2023 and December 31, ~~2021,~~2022, the balance of our equity-method investment related to the Fantasia II JV was approximately ~~$1.3~~$1.2 million and ~~$1.3~~$1.2 million, respectively.

Summit Fantasia Holdings III, LLC

The Fantasia III JV will continue until an event of dissolution occurs, as defined in the limited liability company agreement of the Fantasia III JV (the “Fantasia III LLC Agreement”).

Under the Fantasia III LLC Agreement, net operating cash flow of the Fantasia III JV is distributed quarterly, first to the Operating Partnership and Fantasia pari passu until each member has received an amount equal to its accrued, but unpaid 9% return, and thereafter 75% to Fantasia and 25% to the Operating Partnership. All capital proceeds from the sale of the properties held by the Fantasia III JV, a refinancing or another capital event, will be paid first to the Operating Partnership and Fantasia pari passu until each has received an amount equal to its accrued but unpaid 9% return plus its total capital contribution, and thereafter 75% to Fantasia and 25% to the Operating Partnership.

As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the balance of our equity-method investment related to the Fantasia III JV was approximately ~~$1.5~~$1.6 million and ~~$1.5~~$1.6 million, respectively.

~~Table of Contents~~

Summit Fantasy Pearl Holdings, LLC

The FPH JV will continue until an event of dissolution occurs, as defined in the limited liability company agreement of the FPH JV (the “FPH LLC Agreement”).

Under the FPH LLC Agreement, net operating cash flow of the FPH JV is distributed quarterly, first to the members pari passu until each member has received an amount equal to its accrued, but unpaid 9% return, and thereafter 65.25% to Fantasy, 7.5% to Atlantis, 7.25% to Fantasia and 20% to the Operating Partnership. All capital proceeds from the sale of the properties held by the FPH JV, a refinancing or another capital event, will be paid to the members pari passu until each has received an amount equal to its accrued but unpaid 9% return plus its total capital contribution, and thereafter 65.25% to Fantasy, 7.5% to Atlantis, 7.25% to Fantasia, and 20% to the Operating Partnership.

AsIn December 2022, Summit recorded an impairment of ~~June 30, 2022~~approximately $0.2 million in the FPH JV due to issues related to tenant operations, and ~~December 31, 2021, the balance of~~consequently, reduced our equity-method investment ~~related~~balance to ~~the FPH JV was approximately $0.3 million and $0.2 million, respectively.~~

~~Indiana JV~~

~~In June 2021, we sold our 15% interest in the Indiana JV for approximately $5.4 million in cash. As of June 30, 2022 and December 31, 2021, we have a 0% interest in the Indiana JV.~~

~~Summarized Financial Data for Equity-Method Investments~~

~~Our Equity-Method Investments are significant equity-method investments in the aggregate.~~

~~The results of operations of our Equity-Method Investments for the three months ended June 30, 2022 are summarized below:~~

Fantasia

Fantasia

Fantasia

FPH

Combined


SUL JV

JV

II JV

III JV

JV

Total

Revenue

$
5,240,000

$
617,000

$
716,000

$
2,065,000

$
898,000

$
9,536,000

Income (loss) from operations

$
1,469,000

$
(3,499,000)

$
507,000

$
1,017,000

$
413,000

$
(93,000)

Net income (loss)

$
179,000

$
(3,548,000)

$
276,000

$
501,000

$
530,000

$
(2,062,000)

Summit interest in Equity-Method Investments net income (loss)

$
18,000

$
(1,242,000)

$
55,000

$
50,000

$
53,000

$
(1,066,000)
⁽¹⁾

~~(1)~~

~~Included in the loss from equity-method investees in the condensed consolidated statements of operations is an additional $65,000 of impairment related to the Fantasia JV Equity-Method Investment.~~

~~The results of operations of our Equity-Method Investments for the three months ended June 30, 2021 are summarized below:~~

Fantasia

Fantasia

Fantasia

FPH

Indiana

Combined

SUL JV

JV

II JV

III JV

JV

JV

Total
Revenue

$
5,091,000

$
951,000

$
921,000

$
2,057,000

$
893,000

$
(2,594,000)
⁽¹⁾
$
7,319,000
Income (loss) from operations

$
1,810,000

$
72,000

$
479,000

$
1,020,000

$
412,000

$
(3,447,000)

$
346,000
Net income (loss)

$
609,000

$
82,000

$
243,000

$
492,000

$
81,000

$
(4,969,000)

$
(3,462,000)
Summit interest in Equity-Method Investments net income (loss)

$
61,000

$
29,000

$
49,000

$
49,000

$
8,000

$
(746,000)

$
(550,000)

~~(1)~~

This amount has been revised to reflect the revenues of the Indiana JV prior to the sale of our 15% interest, which includes $0.6 million in above-market lease amortization and $0.2 million in interest income. There was no impact on the loss allocated to the Company as a result of this revision.

~~The results of operations of our Equity-Method Investments for the six months ended June 30, 2022 are summarized below:~~$0.

1815

Table of Contents

Fantasia

Fantasia

Fantasia

FPH

Combined


SUL JV

JV

II JV

III JV

JV

Total

Revenue

$
10,435,000

$
1,344,000

$
1,431,000

$
4,130,000

$
1,796,000

$
19,136,000

Income (loss) from operations

$
3,067,000

$
(2,328,000)

$
998,000

$
1,988,000

$
833,000

$
4,558,000

Net income (loss)

$
626,000

$
(2,472,000)

$
536,000

$
978,000

$
1,741,000

$
1,409,000

Summit interest in Equity-Method Investments net income (loss)

$
63,000

$
(866,000)

$
107,000

$
98,000

$
174,000

$
(424,000)
⁽¹⁾

~~(1)~~

~~The results~~As of ~~operations~~June 30, 2023 and December 31, 2022, the balance of our ~~Equity-Method Investments for~~equity-method investment related to the ~~six months ended June 30, 2021 are summarized below:~~FPH JV was $0.

Fantasia

Fantasia

Fantasia

FPH



Combined

SUL JV

JV

II JV

III JV

JV

Indiana JV

Total
Revenue

$
10,267,000

$
1,881,000

$
1,841,000

$
4,113,000

$
1,783,000

$
(3,166,000)
⁽¹⁾
$
16,719,000
Income (loss) from operations

$
3,357,000

$
143,000

$
964,000

$
2,057,000

$
833,000

$
(5,093,000)

$
2,261,000
Net income (loss)

$
787,000

$
369,000

$
492,000

$
1,007,000

$
928,000

$
(8,567,000)

$
(4,984,000)
Summit interest in Equity-Method Investments net income (loss)

$
79,000

$
129,000

$
98,000

$
102,000

$
93,000

$
(1,286,000)

$
(785,000)

~~(1)~~

This amount has been revised to reflect the revenues of the Indiana JV prior to the sale of our 15% interest, which includes $1.5 million in above-market lease amortization and $0.4 million in interest income. There was no impact on the loss allocated to the Company as a result of this revision.

Distributions from Equity-Method Investments

As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, we have distributions receivable, which are included in tenant and other receivables in our condensed consolidated balance sheets, as follows:


	June 30,		December 31,		June 30,		December 31,
	2022		2021		2023		2022
SUL JV	$	272,000	$	273,000	$	266,000	$	259,000
Fantasia JV		235,000		205,000
Fantasia I JV						—		—
Fantasia II JV		56,000		54,000		30,000		55,000
Fantasia III JV		33,000		22,000		54,000		22,000
FPH JV		51,000		28,000		64,000		64,000
Total	$	647,000	$	582,000	$	414,000	$	400,000

For the six months ended June 30, ~~2022~~2023 and ~~2021,~~2022, we have received cash distributions, which are included in our cash flows from operating activities in tenant and other receivables, and cash flows from investing activities, as follows:


	Six Months Ended June 30, 2022						Six Months Ended June 30, 2021						Six Months Ended June 30, 2023						Six Months Ended June 30, 2022
			Cash Flow		Cash Flow				Cash Flow		Cash Flow				Cash Flow		Cash Flow				Cash Flow		Cash Flow
	Total Cash		from		from		Total Cash		from		from		Total Cash		from		from		Total Cash		from		from
	Distributions		Operating		Investing		Distributions		Operating		Investing		Distributions		Operating		Investing		Distributions		Operating		Investing
	Received		Activities		Activities		Received		Activities		Activities		Received		Activities		Activities		Received		Activities		Activities
SUL JV	$	286,000	$	63,000	$	223,000	$	484,000	$	79,000	$	405,000	$	266,000	$	92,000	$	174,000	$	286,000	$	63,000	$	223,000
Fantasia JV		0		0		0		0		0		0
Fantasia I JV														—		—		—		—		—		—
Fantasia II JV		156,000		107,000		49,000		148,000		98,000		50,000		135,000		106,000		29,000		156,000		107,000		49,000
Fantasia III JV		48,000		48,000		—		123,000		101,000		22,000		12,000		12,000		—		48,000		48,000		—
FPH JV		56,000		56,000		0		77,000		77,000		0		—		—		—		56,000		56,000		—
Indiana JV		—		—		—		773,000		0		773,000
Total	$	546,000	$	274,000	$	272,000	$	1,605,000	$	355,000	$	1,250,000	$	413,000	$	210,000	$	203,000	$	546,000	$	274,000	$	272,000

~~Table of Contents~~

Asset Management Fees

We serve as the manager of our Equity-Method Investments and provide management services in exchange for fees and reimbursements. As the manager, we are paid an annual asset management fee for managing the properties held by our Equity-Method Investments, as defined in those agreements. For the three months ended June 30, ~~2022~~2023 and ~~2021,~~2022, we recorded approximately ~~$0.2~~$0.1 million and ~~$0.3~~$0.2 million, respectively, in asset management fees from our Equity-Method Investments. For each of the six months ended June 30, ~~2022~~2023 and ~~2021,~~2022, we recorded approximately $0.3 million ~~and $0.6 million, respectively,~~ in asset management fees from our Equity-Method Investments (see Note 7).

6. Receivables

Tenant and Other Receivables, Net

Tenant and other receivables, net consists of:


	June 30,		December 31,		June 30,		December 31,
	2022		2021		2023		2022
Straight-line rent receivables	$	3,143,000	$	2,395,000	$	4,468,000	$	3,862,000
Distribution receivables from Equity-Method Investments		647,000		582,000		414,000		400,000
Asset management fees		249,000		323,000		302,000		375,000
Other receivables		221,000		86,000		387,000		383,000
Total	$	4,260,000	$	3,386,000	$	5,571,000	$	5,020,000

Table of Contents

7. Related Party Transactions

Equity-Method Investments

See Notes 5 and 6 for further discussion of distributions and asset management fees related to our Equity-Method Investments.

8. Intangible Lease Assets

Intangible lease assets ~~as of June 30, 2022 and December 31, 2021~~ are as follows:


	June 30,		December 31,		June 30,		December 31,
	2022		2021		2023		2022
In-place leases	$	13,778,000	$	13,778,000	$	13,778,000	$	13,778,000
Less: accumulated amortization		(477,000)		(18,000)		(1,396,000)		(937,000)
In-place leases, net		13,301,000		13,760,000		12,382,000		12,841,000
Above-market leases		959,000		959,000		959,000		959,000
Less: accumulated amortization		(64,000)		(32,000)		(128,000)		(96,000)
Above-market leases, net		895,000		927,000		831,000		863,000
Total intangible lease assets, net	$	14,196,000	$	14,687,000	$	13,213,000	$	13,704,000

For each of the three months ended June 30, ~~2022~~2023 and ~~2021,~~2022, amortization expense for intangible lease assets was approximately $0.2 million, ~~and $0, respectively,~~ of which approximately $16,000 relates to the amortization of above market leases which is included within rental revenues in the accompanying condensed consolidated statements of operations. For each of the six months ended June 30, 2023 and ~~$0, respectively,~~2022, amortization expense for intangible lease assets was approximately $0.5 million, of which approximately $32,000 relates to the amortization of above-market leases which is included within rental revenues in the accompanying condensed consolidated statements of operations. For the six months ended June 30, 2022 and 2021, amortization expense for intangible lease assets was approximately $0.5 million and $0, respectively, of which approximately $32,000 and $0, respectively, relates to the amortization of above-market leases which is included within rental revenues in the accompanying condensed consolidated statements of operations.

~~Table of Contents~~

Expected future amortization of the intangible lease assets as of June 30, ~~2022,~~2023, for the period from July 1, ~~2022~~2023 to December 31, ~~2022~~2023 and for each of the four following years and thereafter ending December 31 are as follows:


Years ending December 31,
July 1, 2022 to December 31, 2022	$	490,000
2023		980,000
July 1, 2023 to December 31, 2023			$	490,000
2024		980,000		980,000
2025		980,000		980,000
2026		980,000		980,000
2027				980,000
Thereafter		9,786,000		8,803,000
	$	14,196,000	$	13,213,000

9. Right of Use (ROU) Asset - Operating

~~On April 1,~~In November 2022, we entered into ~~a temporary space license agreement (“Temporary License”) and a standard office~~an operating lease ~~(“New Lease”) with Lakehills CM-CG LLC (collectively, the “LH Lease”).~~

~~The Temporary License,~~ for ~~space located in Laguna Hills, California, began on April 22, 2022 and expires on the date we move out of such temporary~~ office space or ~~five~~ (5) days after the substantial completion of certain tenant improvements in the office space subject to the New Lease, but in no event later than April 21, 2023. We are entitled to use such office space at no cost during the term of the Temporary License.

~~Concurrent with the execution of the Temporary License, we entered into the New Lease which begins on or about November 1, 2022~~(“Office Lease”) for a period of sixty-six (66) months, with a five-year renewal option. The office space subject to the ~~New~~Office Lease is ~~also~~ located in Laguna Hills, California. The ~~New~~Office Lease provides for the abatement of the base rent for the second full calendar month (January 2023) through the seventh full calendar month of the lease ~~term.~~term (June 2023). The initial annual base rent is $204,399 and increases three percent (3%) each year on the anniversary date of the commencement of the ~~New~~Office Lease.

The LHOffice Lease is classified as an operating lease. ~~An ROU asset~~A “right to use” or “ROU asset” represents the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The LHOffice Lease did not provide an explicit rate of interest; therefore we used an estimated incremental borrowing rate of 5% based on a fully collateralized and fully amortizing loan with a maturity date of the same length as the lease that is based on information available at the commencement date in determining the present value of lease payments. ~~At inception, we recorded an ROU asset and lease~~ ~~liability~~ ~~of approximately $888,000. As a result, the Company had non-cash activity of $888,000 for the ROU asset obtained in exchange for new operating lease liabilities.~~ The LHOffice Lease does not contain material residual value guarantees or material restrictive covenants.

Table of Contents

Supplemental balance sheet information related to the LHOffice Lease ~~as of June 30, 2022 is~~are as follows:

Component

Consolidated Balance Sheet Caption


Right of use asset - operating

Other assets, net

$
875,000
Lease liability - operating

Accounts payable and accrued liabilities

$
896,000


Component	Consolidated Balance Sheet Caption	June 30, 2023		December 31, 2022
Right of use asset - operating	Other assets, net	$	766,000	$	833,000
Lease liability - operating	Accounts payable and accrued liabilities	$	957,000	$	933,000

Lease expense is presented as part of continuing operations within general and administrative expenses in the condensed consolidated statements of operations. For the three months ended June 30, 2023, we recognized approximately $45,000 in lease expense and for the six months ended June 30, ~~2022,~~2023, we recognized approximately ~~$20,000~~$90,000 in lease ~~expense and we were not required to make any rent payments.~~expense. The lease payments will be classified within operating activities in the consolidated statements of cash flows. As of June 30, ~~2022,~~2023, we had not made any lease payments and the weighted average remaining lease term is ~~5.8~~4.7 years.

~~Table of Contents~~

~~Pursuant to ASC 842, lease~~Lease payments on the LHOffice Lease for the period from July 1, ~~2022~~2023 to December 31, ~~2022~~2023 and for each of the four following years and thereafter ending December 31 are as follows:


Year	Lease payments		Lease payments
July 1, 2022 to December 31, 2022	$	17,000
2023		120,000
July 1, 2023 to December 31, 2023			$	103,000
2024		212,000		211,000
2025		218,000		217,000
2026		224,000		224,000
2027				231,000
Thereafter		310,000		99,000
Total lease payments	$	1,101,000	$	1,085,000
Less imputed interest ($166,000) and moving expense reimbursement ($39,000)		(205,000)
Less imputed interest				(128,000)
Total lease liability	$	896,000	$	957,000

10. Concentration of Risk

Our cash is generally invested in short-term money market instruments. As of June 30, ~~2022,~~2023, we had cash ~~and cash equivalent~~ accounts in excess of FDIC-insured limits. ~~However,~~During March 2023, in response to the banking crisis, we dotransferred cash balances in excess of FDIC-insured limits from a smaller regional bank to a multi-national bank. To date, we have not ~~believe the risk associated with this excess is significant.~~experienced losses or lack of access to cash in our cash and cash equivalent accounts.

As of June 30, ~~2022,~~2023, we owned 8eight properties in Georgia, 4four properties in California, 3three properties in Oregon, 1one property in Texas, 1one property in Illinois, and 1one property in Arizona (excluding the 35 properties held by our Equity-Method Investments). Accordingly, there is a geographic concentration of risk subject to economic conditions in certain states.

Additionally, for the three months ended June 30, ~~2022,~~2023, we leased our 16 ~~of our~~ real estate properties ~~were leased~~ to 14 different tenants under long-term triple net leases, and 3three of the 14 tenants each represented more than 10% of our rental revenue. For the three months ended June 30, ~~2021, we leased~~2022, 16 of our 7 real estate properties were leased to 514 different tenants under long-term triple net leases, and 3three of the ~~five~~14 tenants each represented more than 10% of our rental revenue.

For the six months ended June 30, 2023, 16 of our real estate properties were leased to 14 different tenants under long-term triple net leases, and three of the 14 tenants each represented more than 10% of our rental revenue. For the six months ended June 30, 2022, 16 of our real estate properties were leased to 14 different tenants under long-term triple net leases, and 3three of the 14 tenants each represented more than 10% of our rental revenue. For the six months ended June 30, 2021, we leased our 7 real estate properties to 5 different tenants under long-term triple net leases, and 3 of the five tenants each represented more than 10% of our rental revenue.

As of June 30, ~~2022,~~2023, our GA8 Properties are considered to be a significant asset concentration as the aggregate net assets of the GA8 Properties were greater than 20% of our total assets due to cross-default provisions in the leases.

Table of Contents

11. Fair Value Measurements of Financial Instruments

Our condensed consolidated balance sheets include the following financial instruments: cash and cash equivalents, restricted cash, tenant and other receivables, certain other assets, accounts payable and accrued liabilities, security deposits and loans payable. With the exception of the ~~HUD-insured~~ loans payable discussed below, we consider the carrying values to approximate fair value for such financial instruments because of the short period of time between origination of the instruments and their expected ~~payment and for our Oxford and CIBC loans (per Note 4), the carrying amount approximates fair value because the borrowings are based on variable market interest rates.~~payment.

As of June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the fair value of our HUD-insured loans payable was ~~$42.9~~$36.5 million and ~~$52.5~~$38.9 million, compared to the principal balance (excluding debt discount) of ~~$45.6~~$44.4 million and ~~$46.1~~$45.0 million, respectively. The fair value of loans payable was estimated using lending rates available to us for financial instruments with similar terms and maturities. ~~To estimate~~The fair value as of ~~June 30, 2022, we used~~our fixed rate debt was estimated by discounting the future cash ~~flow analyses, based on~~flows using the current ~~interest~~ rates at which similar loans would be made to borrowers with similar credit ratings and for ~~similar types of borrowing arrangements.~~the same remaining maturities. As the inputs to our valuation estimate are neither observable in nor supported by market activity, our loans payable are classified as Level 3 liability within the fair value hierarchy.

As ~~a result~~ of our ongoing analysis for potential impairment of our investments in real estate, we may be required to adjust the carrying value of certain assets to their estimated fair values, or estimated fair value less selling costs, under certain circumstances. NaN impairments were recorded during the three and six months ended June 30, ~~2022 and 2021.~~

~~Table of Contents~~

~~At June 30, 2022~~2023 and December 31, ~~2021,~~2022, we believe the carrying amounts of our variable rate debt are reasonably estimated at their notional amounts as there have been minimal changes to the fixed spread portion of interest rates for similar loans observed in the market, and as the variable portion of our interest rates fluctuate with the associated market indices. As the inputs to our valuation estimate are neither observable in nor supported by market activity, our loans payable are classified as Level 3 liability within the fair value hierarchy.

As of June 30, 2023 and December 31, 2022, we do not have any significant financial assets or financial liabilities that are measured at fair value on a recurring basis in our condensed consolidated financial statements.

12. Commitments and Contingencies

We inspect our properties under a Phase I assessment for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist, we are not currently aware of any environmental liability with respect to the properties that would have a material effect on our consolidated financial condition, results of operations and cash flows. Further, we are not aware of any environmental liability or any unasserted claim or assessment with respect to an environmental liability that we believe would require additional disclosure or the recording of a loss contingency.

Our commitments and contingencies include the usual obligations of real estate owners and licensed operators in the normal course of business. In the opinion of management, these matters are not expected to have a material impact on our consolidated financial condition, results of operations and cash flows. We are also subject to contingent losses resulting from litigation against the Company.

Table of Contents

Legal Proceedings

HCRE

In September 2015, a bankruptcy petition was filed against Healthcare Real Estate Partners, LLC (“HCRE”) by the investors in Healthcare Real Estate Fund, LLC and Healthcare Real Estate Qualified Purchasers Fund, LLC (collectively, the “Funds”). HCRE did not timely respond to the involuntary petition and the Bankruptcy Court entered an Order of Relief making HCRE a debtor in bankruptcy. As a result, HCRE was removed as manager under the Funds’ operating agreement. Thereafter the Company became the manager of the Funds and purchased the investors’ interests in the Funds for approximately $0.9 million. Following the subsequent dismissal of the involuntary bankruptcy petition filed against it, HCRE filed a motion for attorneys’ fees and damages and a separate complaint for violation of the automatic stay against the petitioning creditors and the Company in the United States Bankruptcy Court of the District of Delaware. The Bankruptcy Court granted a motion to dismiss the complaint for violation of the automatic stay filed jointly by the petitioning creditors and us, and dismissed the complaint with prejudice. HCRE appealed the Bankruptcy Court’s decision to the United States District Court for the District of Delaware which affirmed the Bankruptcy Court’s dismissal of the complaint in a decision dated September 9, 2018. On October 11, 2018, HCRE appealed the District Court’s decision affirming the Bankruptcy Court’s dismissal of the complaint to the United States Court of Appeals for the Third Circuit. On October 22, 2019, the Third Circuit granted HCRE’s appeal, reversing the District Court and holding that HCRE could assert the adversary complaint seeking damages for violation of the automatic stay. The Company filed a Petition for Rehearing on November 5, 2019 asserting that HCRE is not entitled to assert a claim for damages for violation of the automatic stay. This Petition was denied and the mandate was issued sending the matter back to the Bankruptcy Court. The Bankruptcy Court held a status conference on February 4, 2021, and subsequently entered scheduling orders to govern discovery and pretrial ~~matters, and discovery is ongoing.~~matters. The parties ~~have~~ filed dispositive motions, including a motion filed by the Company and the petitioning creditors for judgment on the pleadings. On February 4, 2022, the Bankruptcy Court entered an order denying the motion for judgment on the pleadings on the basis that the Bankruptcy Court would consider the points raised therein after trial. The Bankruptcy Court also entered an order denying HCRE’s motion to dismiss certain counterclaims and severing certain other counterclaims asserted by the petitioning creditors and the Company against HCRE on jurisdictional grounds, with the effect that such counterclaims may be pursued in the United States District Court. ~~The~~Trial in the Bankruptcy Court ~~subsequently~~was conducted on January 9 and 10, 2023, with final concluding arguments presented on January 19, 2023. On May 12, 2023, the Court issued an opinion to award the plaintiffs $75,000 for reimbursement of legal fees related to the filing of the involuntary bankruptcy petition plus $517,000 for reimbursement of attorney’s fees related to the stay violation. The court has not yet entered an order or judgment, and will consider post-trial motions before finalizing such amounts. In May 2023, Summit filed notice for an appeal. Based on the assessment by management, as of June 30, 2023, the Company has accrued $75,000 for the reimbursement of legal fees and $0 for the $517,000 in attorney’s fees as we believe that a ~~further amended scheduling order, directing that remaining discovery be completed by~~loss is currently not probable under Accounting Standards Codification 450, “Contingencies.”

Eikanas Dispute

On May 15, ~~2022, which is still ongoing.~~2023, the Board of Directors of the Company sent Kent Eikanas, the then-Chief Executive Officer, written notice of various deficiencies in his performance , thereby initiating the 60-day cure period required by Mr. Eikanas’s Amended and Restated Employment Agreement, dated October 19, 2021. On June 5, 2023, Mr. Eikanas filed a lawsuit against the Company in the Superior Court of California for, among other things, wrongful termination and breach of contract, and seeking unspecified monetary damages. Based on the assessment by management, the Company believes that a loss is currently not probable or estimable under ASC 450, “Contingencies”, and as of June 30, ~~2022 and December 31, 2021~~2023, no accrual has been made with regard to the claim. See Note 14 under Executive Management Changes for further information.

2320

Table of Contents

Indemnification and Employment Agreements

We have entered into indemnification agreements with certain of our executive officers and directors which indemnify them against all judgments, penalties, fines and amounts paid in settlement and all expenses actually and reasonably incurred by him or her in connection with any proceeding. Additionally, effective October 19, 2021, we entered into new employment agreements with our executive officers, Kent Eikanas (Chief Executive Officer) and Elizabeth Pagliarini (Chief Financial Officer), for a term of three years. These employment agreements include customary terms relating to salary, bonus, position, duties and benefits (including eligibility for equity compensation), as well as a cash payment following a change in control of the Company, as defined in such agreements. On July 14, 2023, the employment agreement with Mr. Eikanas was terminated (see Note 14 for further information).

Management of our Equity-Method Investments

As the manager of our Equity-Method Investments, we are responsible for the day-to-day management. Additionally, we could be subject to a capital call from our Equity-Method ~~Investments.~~Investments (see Note 5 for capital call activity).

13. Equity

Share-Based Compensation Plans

Upon the grant of stock options, we determine the exercise price by using our estimated per-share value, which is calculated by aggregating the estimated fair value of our investments in real estate and the estimated fair value of our other assets, subtracting the book value of our liabilities, utilizing a discount for the fact that the shares are not currently traded on a national securities exchange and a lack of a control premium, and divided by the total by the number of our common shares outstanding at the time the options were granted.

The fair value of each grant is estimated on the date of grant using the Black-Scholes option-pricing model. Assumptions required by the model include the risk-free interest rate, the expected life of the options, the expected stock price volatility over the expected life of the options, and the expected distribution yield. Compensation expense for employee stock options is recognized ratably over the vesting term. The expected life of the options was based on the simplified method as we do not have sufficient historical exercise data. The risk-free interest rate was based on the U.S. Treasury yield curve at the date of grant with maturity dates approximating the expected term of the options at the date of grant. Volatility was based on historical volatility of the stock prices for a sample of publicly traded companies with risk profiles similar to ours. The valuation model applied in this calculation utilizes highly subjective assumptions that could potentially change over time, including the expected stock price volatility and the expected life of an option.

On April 1, ~~2022,~~2023, we granted ~~81,000~~80,000 stock options to our non-executive employees under our Summit Healthcare REIT, Inc. 2015 Omnibus Incentive Plan (“Incentive Plan”). The stock options vest monthly beginning on May 1, ~~2022~~2023 and continuing over a three-year period through April 1, ~~2025.~~2026. The options expire 10 years from the grant date. The weighted-average fair value per share of the stock options granted was $0.91.

The estimated fair value using the Black-Scholes option-pricing model with the following weighted average assumptions:


	2022			2023
Stock options granted		81,000			80,000
Expected volatility		36.5	%		37.3	%
Expected term		5.75	years		5.75	years
Risk-free interest rate		2.53	%		3.65	%
Dividend yield		0	%		—	%
Fair value per share	$	0.91		$	0.91

2421

Table of Contents

The following table summarizes our stock options as of June 30, ~~2022:~~2023:


				Weighted						Weighted
		Weighted		Average				Weighted		Average
		Average		Remaining	Aggregate			Average		Remaining	Aggregate
		Exercise		Contractual	Intrinsic			Exercise		Contractual	Intrinsic
	Options	Price		Term	Value		Options	Price		Term	Value
Options outstanding at January 1, 2022	1,867,908	$	2.09
Options outstanding at January 1, 2023							1,948,908	$	2.10
Granted	81,000		2.35				80,000	$	2.18
Exercised	0						—
Cancelled/forfeited	—						—
Options outstanding at June 30, 2022	1,948,908	$	2.10	5.50	$	1,644,000
Options outstanding at June 30, 2023							2,028,908	$	2.10	4.70	$	1,279,000

Options exercisable at June 30, 2022	1,864,046	$	2.09	5.31	$	1,593,000
Options exercisable at June 30, 2023							1,903,852	$	2.09	4.04	$	1,219,000

For our outstanding non-vested options as of June 30, ~~2022,~~2023, the weighted average grant date fair value per share was ~~$0.88.~~$0.91. As of June 30, ~~2022,~~2023, we have unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized as follows:


Years Ending December 31,
July 1, 2022 to December 31, 2022	$	16,000
2023		25,000	$	24,000
2024		25,000		49,000
2025		8,000		32,000
2026				8,000
	$	74,000	$	113,000

The stock-based compensation expense reported for the three months ended June 30, ~~2022~~2023 and ~~2021~~2022 was approximately ~~$6,000~~$10,000 and ~~$11,000,~~$6,000, respectively, and is included in general and administrative expense in the condensed consolidated statements of operations. The stock-based compensation expense reported for the six months ended June 30, ~~2022~~2023 and ~~2021~~2022 was approximately ~~$14,000~~$17,000 and ~~$47,000,~~$14,000, respectively, and is included in general and administrative expense in the condensed consolidated statements of operations.

~~Table of Contents~~

14. ~~Earnings Per Share~~Subsequent Events

The following table presents the calculation of basic and diluted earnings per share (“EPS”) for the Company’s common stock for the three and six months ended June 30, 2022 and 2021, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS:

Three Months Ended

Six Months Ended

June 30,

June 30,


2022

2021

2022

2021
Numerator:




(Loss) income

$
(2,176,000)

$
2,573,000

$
(2,482,000)

$
833,000
(Income) loss attributable to noncontrolling interest

(18,000)

(22,000)

(37,000)

(40,000)
Net (loss) income applicable to common stockholders

$
(2,194,000)

$
2,551,000

$
(2,519,000)

$
793,000

Denominator:

Basic:

Denominator for basic EPS - weighted average shares

23,027,978

23,027,978

23,027,978

23,027,978
Effect of dilutive shares:

Stock options

—

525,628

—

525,628

Denominator for diluted EPS – adjusted weighted average shares

23,027,978

23,553,606

23,027,978

23,553,606

Basic EPS

$
(0.10)

$
0.11

$
(0.11)

$
0.03
Diluted EPS

$
(0.10)

$
0.11

$
(0.11)

$
0.03

Fantasia I JV

On July 3, 2023, the majority member in the Fantasia I JV assigned its 65% interest, for no consideration, to Summit. As such, as of July 2023, Summit will own 100% of Fantasia I JV. The assets and liabilities of the Fantasia I JV will be consolidated in our condensed consolidated financial statements beginning in July 2023. Additionally, there is an executed purchase and sale agreement for the real estate and associated facility which meets the criteria as held for sale, and is expected to close in September 2023.

Executive Management Changes

On July 14, 2023 (the “Termination Date”), the Board of Directors (the “Board”) of the Company terminated, for cause, Kent Eikanas from his position as Chief Executive Officer and Secretary of the Company, after Mr. Eikanas was given written notice of and failed to cure various deficiencies in his performance following the expiration of a 60-day cure period. Per the terms of his employment agreement, upon Mr. Eikanas’ termination for cause, Mr. Eikanas is also deemed to have resigned, as of the Termination Date, from all positions with the Company and its subsidiaries, the Board and any boards of directors or managers of any of Company’s subsidiaries and affiliates.

Effective July 15, 2023, the Board of Directors of the Company appointed Elizabeth Pagliarini as Chief Executive Officer and Secretary. Additionally, effective July 15, 2023, the Board of Directors of the Company also appointed Sharyn Grant Chief Financial Officer and Treasurer of the Company.

2622

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto contained elsewhere in this report. This section contains forward-looking statements, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to numerous risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Forward-looking statements that were true at the time made may ultimately prove to be incorrect or false. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements should be read in light of the risks identified in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, ~~2022.~~2023.

Overview

As of June 30, ~~2022,~~2023, our ownership interests in our 18 real estate properties of senior housing facilities was as follows: 100% ownership of 14 properties and a 95.3% interest in four properties in a consolidated joint venture, Cornerstone Healthcare Partners LLC. Additionally, we have a 10% interest in an unconsolidated equity-method investment that owns 17 properties, a 35% equity interest in an unconsolidated equity-method investment that holds one property, a 20% equity interest in an unconsolidated equity-method investment that holds two properties, a 10% equity interest in an unconsolidated equity-method investment that holds nine properties, and a 10% equity interest in an unconsolidated equity-method investment that holds six ~~properties.~~properties (collectively, our “Equity-Method Investments”). As used in this report, the “Company,” “we,” “us” and “our” refer to Summit Healthcare REIT, Inc. and its consolidated subsidiaries, except where the context otherwise requires.

Our revenues are comprised largely of tenant rental income from our 18 real estate properties, including rents reported on a straight-line basis over the initial term of each tenant lease, resident fees and services and asset management fees resulting from our Equity-Method Investments. We also receive cash distributions from our Equity-Method Investments, which are included in net cash provided by operating activities and net cash provided by investing activities in our condensed consolidated statements of cash flows. Our growth depends, in part, on our ability to continue to raise joint venture equity or other equity, acquire new healthcare properties at attractive prices, negotiate long-term tenant leases with sustainable rental rate escalation terms and control our expenses. Our operations are impacted by property-specific, market-specific, general economic, regulatory and other conditions.

We believe that continued investing in senior housing facilities is accretive to earnings and stockholder value. Senior housing facilities include independent living facilities (“IL”), skilled nursing facilities (“SNF”), assisted living facilities (“AL”), memory care facilities (“MC”) and continuing care retirement communities (“CCRC”). Each of these types of facilities focuses on different segments of the senior ~~population.~~population.Our current properties are SNF, AL, and MC facilities.

~~Coronavirus (COVID-19)~~Current Market and Economic Conditions

The world was, and continues to be, impacted by the COVID-19 pandemic. The healthcare industry was among those most adversely affected by the COVID-19 pandemic. ~~Two of our tenants have~~During 2023 and 2022, we experienced a material adverse effect on ~~their~~the operations of two properties related to COVID-19 ~~and that has affected their ability to make rent payments in 2022 and 2021~~ (see Note 3 to the accompanying Notes to Condensed Consolidated Financial Statements for further information on its impact to ~~us)~~us and see below for the impact on our Equity-Method Investments). ~~The extent to which~~We expect the COVID-19 ~~could~~pandemic will continue to ~~impact~~adversely affect our ~~business, cash flow~~tenants’ and our Company’s financial condition and results of operations, ~~will depend on future developments, which are highly uncertain~~including but not limited to, occupancy, resident leases and ~~cannot be predicted with confidence, including the rate of public acceptance~~related resident fees and ~~usage of vaccines~~service revenues, and the effectiveness of vaccines in limiting the spread of COVID-19 and its variants, resurgences of COVID-19 and, in particular, new and more contagious and/or vaccine resistant variants, actions taken to contain the spread of COVID-19 and how quickly and to what extent normal economicadditional labor and operating ~~conditions can resume.~~

~~Summit Portfolio Properties~~

~~On July 2, 2021, we acquired three properties in California (the “CA3 Properties”) for approximately $20.1 million. See Notes 3 and 4~~expenses. The fluidity of this situation precludes any prediction as to the ~~accompanying Notes~~ultimate material adverse impact on the demand for senior housing and skilled nursing and presents material uncertainty and risk with respect to ~~Condensed Consolidated Financial Statements for further information regarding the purchase price~~our business, operations, financial condition and ~~associated financing arrangements.~~liquidity, including recording impairments, lease modifications and credit losses in future periods.

2723

Table of Contents

~~On December~~Recently, the broader economy began experiencing increased levels of inflation, higher interest rates and tightening monetary and fiscal policies. The Federal Reserve has increased its targeted range for the federal funds rate, leading to increased interest rates and it foresees further interest rate increases. We currently have fixed and variable interest rates for our loans. The rise in overall interest rates has caused an increase in our variable rate borrowing costs and our overall cost of capital, resulting in an increase in interest expense. The higher interest rates imposed by the Federal Reserve to address inflation may also adversely impact real estate asset values. In addition, a prolonged period of high and persistent inflation could cause an increase in our expenses. The current market and economic conditions could have a material impact on our business, cash flow and results of operations. It could also impact our ability to find suitable acquisitions, sell properties, and raise equity and debt capital.

Summit Portfolio Properties

At June 30, ~~2021, we acquired eight~~2023, our portfolio consisted of 18 real estate properties as noted above in ~~Georgia (the “GA8 Properties”) for approximately $130.0 million. See Notes~~the Overview section of this Item 2, 16 of which were 100% triple-net leased to the tenants of the related facilities. The other two properties are each 100% leased to an affiliated subsidiary (see Note 3 ~~and 4~~ to the accompanying Notes to Condensed Consolidated Financial Statements under Pennington Gardens Operations LLC (“Pennington Gardens”) and Sundial Operations LLC (“Sundial”), collectively, the “Operated Properties”) for ~~further information regarding the purchase price~~which we operate directly and ~~associated financing arrangements.~~earn resident fees and services revenue.

The following table provides summary information (excluding the 35 properties held by our unconsolidated Equity-Method Investments) regarding these properties as of June 30, ~~2022:~~2023:


			Square	Purchase
	Properties	Beds	Footage	Price
SNF	15	1,354	406,135	$	181,795,000
AL or AL/MC	3	221	136,765		25,525,000
Total Real Estate Properties	18	1,575	542,900	$	207,320,000

2022

Lease
Property

Location

Date Purchased

Type

Beds

Revenue ⁽¹⁾
Sheridan Care Center

Sheridan, OR

August 3, 2012

SNF

51

$
246,000
Fernhill Care Center

Portland, OR

August 3, 2012

SNF

63

262,000
Friendship Haven Healthcare and Rehabilitation Center

Galveston County TX

September 14, 2012

SNF

150

706,000
Pacific Health and Rehabilitation Center

Tigard, OR

December 24, 2012

SNF

73

484,000
Brookstone of Aledo

Aledo, IL

July 2, 2013

AL

66

382,000
Sundial Assisted Living ⁽²⁾

Redding, CA

December 18, 2013

AL

65

—
Pennington Gardens ⁽²⁾

Chandler, AZ

July 17, 2017

AL/MC

90

—
Yucaipa Hill Post Acute

Yucaipa, CA

July 2, 2021

SNF

82

532,000
Creekside Post Acute

Yucaipa, CA

July 2, 2021

SNF

59

238,000
University Post Acute

Mentone, CA

July 2, 2021

SNF

50

227,000
Calhoun Health Center

Calhoun, GA

December 30, 2021

SNF

100

239,000
Maple Ridge Health Care Center

Cartersville, GA

December 30, 2021

SNF

74

947,000
Chatsworth Health Care Center

Chatsworth, GA

December 30, 2021

SNF

120

1,729,000
East Lake Arbor

Decatur, GA

December 30, 2021

SNF

103

451,000
Fairburn Health Care Center

Fairburn, GA

December 30, 2021

SNF

120

724,000
Grandview Health Care Center

Jasper, GA

December 30, 2021

SNF

60

532,000
Rosemont at Stone Mountain

Stone Mountain, GA

December 30, 2021

SNF

149

1,367,000
Willowwood Nursing Center & Rehab

Flowery Branch, GA

December 30, 2021

SNF

100

515,000
Total





1,575

Table of Contents


					2023
					Lease
Property	Location	Date Purchased	Type	Beds	Revenue ⁽¹⁾
Sheridan Care Center	Sheridan, OR	August 3, 2012	SNF	51	$	246,000
Fernhill Care Center	Portland, OR	August 3, 2012	SNF	63		262,000
Friendship Haven Healthcare and Rehabilitation Center	Galveston County TX	September 14, 2012	SNF	150		706,000
Pacific Health and Rehabilitation Center	Tigard, OR	December 24, 2012	SNF	73		484,000
Brookstone of Aledo	Aledo, IL	July 2, 2013	AL	66		382,000
Sundial Assisted Living ⁽²⁾	Redding, CA	December 18, 2013	AL	65		—
Pennington Gardens ⁽²⁾	Chandler, AZ	July 17, 2017	AL/MC	90		—
Yucaipa Hill Post Acute	Yucaipa, CA	July 2, 2021	SNF	82		532,000
Creekside Post Acute	Yucaipa, CA	July 2, 2021	SNF	59		238,000
University Post Acute	Mentone, CA	July 2, 2021	SNF	50		227,000
Calhoun Health Center	Calhoun, GA	December 30, 2021	SNF	100		239,000
Maple Ridge Health Care Center	Cartersville, GA	December 30, 2021	SNF	74		947,000
Chatsworth Health Care Center	Chatsworth, GA	December 30, 2021	SNF	120		1,729,000
East Lake Arbor	Decatur, GA	December 30, 2021	SNF	103		451,000
Fairburn Health Care Center	Fairburn, GA	December 30, 2021	SNF	120		724,000
Grandview Health Care Center	Jasper, GA	December 30, 2021	SNF	60		532,000
Rosemont at Stone Mountain	Stone Mountain, GA	December 30, 2021	SNF	149		1,367,000
Willowwood Nursing Center & Rehab	Flowery Branch, GA	December 30, 2021	SNF	100		515,000
Total				1,575

(1)

Represents year-to-date rental revenue based on in-place leases, including straight-line rent, through June 30, ~~2022~~2023 and excluding $1.2 million in tenant reimbursement revenue and $0.03 million in above-market lease ~~amortization and $0.3 million in revenue related to the settlements for the termination of the Pennington Gardens and Sundial Assisted Living leases.~~amortization.

(2)

See Note 3 to the accompanying Notes to Condensed Consolidated Financial Statements for further information on these two properties. ~~Rents~~Lease revenue due under the Pennington Gardens ~~Operations~~ and Sundial ~~Operations~~intercompany leases are eliminated in ~~consolidation.~~consolidation and revenue is reflected in resident fees and services in the accompanying condensed consolidated statements of operations for the Operated Properties.

~~Table of Contents~~

Summit Equity-Method Investment Portfolio Properties

We continue to believe that raising institutional ~~joint venture equity~~capital to make acquisitions will be accretive to shareholder value. Our primary source of ~~equity~~capital since 2015 has been institutional funds raised through a joint venture structure and accounted for as equity-method investments. We still believe this is a prudent strategy for growth; however, in the future, we may raise additional equity capital through alternative methods if warranted by market conditions.

A summary of the condensed combined financial data for the balance sheets and statements of income for all unconsolidated Equity-Method Investments are as follows (see below under Indiana JV for information regarding the sale of our equity interest in the Indiana JV on June 11, 2021 and see Note 5 to the accompanying Notes to Condensed Consolidated Financial Statements; accordingly, the financial information for the Indiana JV is not included in the June 30, 2022 or December 31, 2021 condensed combined balance sheet and for the three and six months ended June 30, 2021 condensed combined statement of income below):

June 30,

December 31,
Condensed Combined Balance Sheets:

2022

2021
Total Assets

$
267,193,000

$
286,572,000
Total Liabilities

$
190,974,000

$
213,812,000
Members Equity:

Summit

$
7,703,000

$
8,017,000
JV Partners

$
68,516,000

$
64,743,000
Total Members Equity

$
76,219,000

$
72,760,000

Table of Contents

Three Months Ended

Six Months Ended

June 30,

June 30,
Condensed Combined Statements of Operations:

2022

2021

2022

2021
Total Revenue

$
9,536,000

$
9,913,000

$
19,136,000

$
19,885,000
(Loss) income from Operations

$
(93,000)

$
3,793,000

$
4,558,000

$
7,354,000
Net (loss) income

$
(2,062,000)

$
1,507,000

$
1,409,000

$
3,583,000

Summit equity interest in Equity-Method Investments net (loss) income

$
(1,066,000)

$
196,000

$
(424,000)

$
501,000
JV Partners interest in Equity-Method Investments net (loss) income

$
(996,000)

$
1,311,000

$
1,832,000

$
3,083,000

Summit Union Life Holdings, LLC

In April 2015, through our operating partnership (“Operating Partnership”), we formed Summit Union Life Holdings, LLC (“SUL JV”) with Best Years, LLC (“Best Years”), an unrelated entity and a U.S.-based affiliate of Union Life Insurance Co, Ltd. (a Chinese corporation), and entered into a limited liability company with Best Years with respect to the SUL JV (the “SUL LLC Agreement”). The SUL JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements.

~~The following reconciles our 10% equity investment in the SUL JV from inception through June 30, 2022:~~

JV 2 Properties (Colorado, Oregon and Virginia) – April 2015

$
1,100,000
Creative Properties (Texas) – October 2015

837,000
Cottage Properties (Wisconsin) – December 2015

1,811,000
Riverglen (New Hampshire) – April 2016

424,000
Delaware Properties – September 2016

1,846,000
Total investments

6,018,000
Income from equity-method investee

1,634,000
Distributions

(4,370,000)
Total investment at June 30, 2022

$
3,282,000

~~Table of Contents~~

~~A summary of the condensed consolidated financial data for the balance sheets and statements of income for the unconsolidated SUL JV, of which we own a 10% equity interest, is as follows:~~

June 30,

December 31,
Condensed Consolidated Balance Sheets of SUL JV:

2022

2021
Real estate properties and intangibles, net

$
123,237,000

$
125,183,000
Cash and cash equivalents

4,595,000

4,929,000
Other assets

13,001,000

14,322,000
Total Assets:

$
140,833,000

$
144,434,000

Loans payable, net

$
90,692,000
⁽¹⁾
$
98,432,000
Other liabilities

8,240,000

8,463,000
Members’ equity:

Best Years

38,504,000

34,568,000
Summit

3,397,000

2,971,000
Total Liabilities and Members’ Equity

$
140,833,000

$
144,434,000

~~(1)~~

~~In June 2022, the $6.8 million loan payable related to the Cottage Properties was paid off using funds received from the members’ (Summit’s portion was approximately $650,000).~~

Three Months Ended

Six Months Ended

June 30,

June 30,
Condensed Consolidated Statements of Income of SUL JV:

2022

2021

2022

2021
Total revenue

$
5,240,000

$
5,091,000

$
10,435,000

$
10,267,000
Property operating expenses

(2,644,000)

(1,902,000)

(5,120,000)

(4,157,000)
Net operating income

2,596,000

3,189,000

5,315,000

6,110,000
General and administrative expense

(104,000)

(108,000)

(205,000)

(208,000)
Depreciation and amortization expense

(1,023,000)

(1,271,000)

(2,043,000)

(2,545,000)
Income from operations

1,469,000

1,810,000

3,067,000

3,357,000
Interest expense

(1,075,000)

(1,155,000)

(2,179,000)

(2,314,000)
Amortization of debt issuance costs

(216,000)

(51,000)

(265,000)

(104,000)
Other income (expense)

1,000

5,000

3,000

(152,000)
Net income

$
179,000

$
609,000

$
626,000

$
787,000

Summit equity interest in SUL JV net income

$
18,000

$
61,000

$
63,000

$
79,000

~~Table of Contents~~

~~As of June 30, 2022, the 17 properties held by SUL JV, our unconsolidated 10% equity-method investment, of which 11 are 100% leased on a triple net basis and six are operated directly, are as follows:~~


			~~Number of~~
~~Property~~	~~Location~~	~~Type~~	~~Beds~~
~~Lamar Estates~~	~~Lamar, CO~~	~~SNF~~	60
~~Monte Vista Estates~~	~~Monte Vista, CO~~	~~SNF~~	60
~~Myrtle Point Care Center~~	~~Myrtle Point, OR~~	~~SNF~~	55
~~Gateway Care and Retirement Center~~	~~Portland, OR~~	~~SNF/IL~~	91
~~Applewood Retirement Community~~	~~Salem, OR~~	IL	69
~~Shenandoah Senior Living~~	~~Front Royal, VA~~	AL	78
~~Pine Tree Lodge Nursing Center~~	~~Longview, TX~~	~~SNF~~	92
~~Granbury Care Center~~	~~Granbury, TX~~	~~SNF~~	~~181~~
~~Twin Oaks Nursing Center~~	~~Jacksonville, TX~~	~~SNF~~	~~116~~
~~Dogwood Trails Manor~~	~~Woodville, TX~~	~~SNF~~	90
~~Carolina Manor~~	~~Appleton, WI~~	AL	45
~~Carrington Manor~~	~~Green Bay, WI~~	AL	20
~~Marla Vista Manor~~	~~Green Bay, WI~~	AL	40
~~Marla Vista Gardens~~	~~Green Bay, WI~~	AL	20
~~Riverglen House of Littleton~~	~~Littleton, NH~~	AL	59
~~Atlantic Shore Rehabilitation and Health Center~~	~~Millsboro, DE~~	~~SNF~~	~~181~~
~~Pinnacle Rehabilitation and Health Center~~	~~Smyrna, DE~~	~~SNF~~	~~151~~
~~Total:~~			~~1,408~~

Equity-Method Partner – Fantasia Investment III LLC

In 2016 and 2017, through our Operating Partnership, we entered into three separate limited liability company agreements (collectively, the “Fantasia Agreements”) with Fantasia Investment III LLC (“Fantasia”), an unrelated entity and a U.S.-based affiliate of Fantasia Holdings Group Co., Limited (a Chinese corporation listed on the Stock Exchange of Hong Kong (HKEX)), and formed three separate companies, Summit Fantasia Holdings, LLC (“Fantasia I”I JV”), Summit Fantasia Holdings II, LLC (“Fantasia ~~II”~~II JV”) and Summit Fantasia Holdings III, LLC (“Fantasia ~~III”~~III JV”) (collectively, the “Fantasia JVs”). The Fantasia JVs are not consolidated in our condensed consolidated financial statements and are accounted for under the equity-method in our condensed consolidated financial statements. Through the Fantasia JVs: we own a 35% interest in one senior housing facility located in ~~California (in March 2022, we sold one facility located in Oregon);~~California; a 20% interest in two skilled nursing facilities located in Rhode Island; and a 10% interest in nine skilled nursing facilities located in Connecticut.

~~The following reconciles our equity investments in the Fantasia JVs from inception through June 30, 2022:~~

Summit Fantasia Holdings, LLC – October 2016

$
2,593,000
Summit Fantasia Holdings II, LLC – February 2017

1,923,000
Summit Fantasia Holdings III, LLC – August 2017

1,954,000
Total investment

6,470,000
Income from Fantasia JVs

813,000
Distributions

(3,396,000)
Total Fantasia investments at June 30, 2022

$
3,887,000

~~Table of Contents~~

~~A summary of the condensed combined financial data for the balance sheets and statements of income for the unconsolidated Fantasia JVs, of which we own a 10% to 35% equity interest, is as follows:~~

June 30,

December 31,
Condensed Combined Balance Sheets of Fantasia JVs:

2022

2021
Real estate properties, net⁽²⁾

$
84,443,000

$
88,908,000
Cash and cash equivalents

6,050,000

8,135,000
Assets held for sale ⁽¹⁾

—

10,454,000
Other assets

7,648,000

6,834,000
Total Assets:

$
98,141,000

$
114,331,000

Loans payable, net

$
62,107,000

$
67,154,000
Liabilities held for sale ⁽¹⁾

—

7,537,000
Other liabilities

7,322,000

8,885,000
Members’ equity:

Fantasia JVs

24,760,000

25,967,000
Summit

3,952,000

4,788,000
Total Liabilities and Members’ Equity

$
98,141,000

$
114,331,000

~~(1)~~

In May 2021, the Fantasia I JV entered into an agreement to sell one of the properties in the Summit Fantasia Holdings, LLC equity-method investment; therefore, such property was accounted for as Held for Sale as of December 31, 2021. In March 2022, the property was sold for $11.0 million and Fantasia I recorded a gain of $1.2 million.

~~(2)~~

~~In June 2022, Fantasia I recorded an impairment of approximately $3.2 million related to the Sun Oak Assisted Living property.~~

Three Months Ended

Six Months Ended

June 30,

June 30,
Condensed Combined Statements of Operations of Fantasia JVs:

2022

2021

2022

2021
Total revenue

$
3,398,000

$
3,929,000

$
6,905,000

$
7,835,000
Property operating expenses

(1,397,000)

(1,518,000)

(2,763,000)

(2,994,000)
Net operating income

2,001,000

2,411,000

4,142,000

4,841,000
General and administrative expense

(127,000)

(138,000)

(256,000)

(248,000)
Depreciation and amortization expense

(607,000)

(702,000)

(1,233,000)

(1,429,000)
Impairment on real estate property

(3,242,000)

—

(3,242,000)

—
Gain on sale of real estate

—

—

1,247,000

—
(Loss) income from operations

(1,975,000)

1,571,000

658,000

3,164,000
Interest expense

(769,000)

(893,000)

(1,569,000)

(1,786,000)
Amortization of debt issuance costs

(39,000)

(16,000)

(62,000)

(32,000)
Other income

12,000

155,000

15,000

522,000
Net (loss) income

$
(2,771,000)

$
817,000

$
(958,000)

$
1,868,000

Summit equity interest in Fantasia JVs net (loss) income

$
(1,137,000)

$
127,000

$
(661,000)

$
329,000

~~Table of Contents~~

~~As of June 30, 2022, the 12 properties in Fantasia JVs, our unconsolidated equity-method investments, are all 100% leased on a triple net basis, and are as follows:~~


			~~Number of~~
~~Property~~	~~Location~~	~~Type~~	~~Beds~~
~~Sun Oak Assisted Living~~	~~Citrus Heights, CA~~	~~AL/MC~~	78
~~Trinity Health and Rehabilitation Center~~	~~Woonsocket, Rhode Island~~	~~SNF~~	~~185~~
~~Hebert Nursing Home~~	~~Smithfield, Rhode Island~~	~~SNF~~	~~133~~
~~Chelsea Place Care Center~~	~~Hartford, CT~~	~~SNF~~	~~234~~
~~Touchpoints at Manchester~~	~~Manchester, CT~~	~~SNF~~	~~131~~
~~Touchpoints at Farmington~~	~~Farmington, CT~~	~~SNF~~	~~105~~
~~Fresh River Healthcare~~	~~East Windsor, CT~~	~~SNF~~	~~140~~
~~Trinity Hill Care Center~~	~~Trinity Hill, CT~~	~~SNF~~	~~144~~
~~Touchpoints at Bloomfield~~	~~Bloomfield, CT~~	~~SNF~~	~~150~~
~~Westside Care Center~~	~~Westside, CT~~	~~SNF~~	~~162~~
~~Silver Springs Care Center~~	~~Meriden, CT~~	~~SNF~~	~~159~~
~~Touchpoints of Chestnut~~	~~Chestnut, CT~~	~~SNF~~	60
~~Total:~~			~~1,681~~

Summit Fantasy Pearl Holdings, LLC

In October 2017, through our Operating Partnership, we entered into a limited liability company agreement (the “FPH LLC Agreement”) with Fantasia, Atlantis Senior Living 9, LLC, a Delaware limited liability company (“Atlantis”), and Fantasy Pearl LLC, a Delaware limited liability company (“Fantasy”), and formed Summit Fantasy Pearl Holdings, LLC (the “FPH JV”). The FPH JV is not consolidated in our condensed consolidated financial statements and is accounted for under the equity-method in our condensed consolidated financial statements.

The following reconciles our equity ~~investment~~investments in ~~the FPH JV~~our Equity-Method Investments from inception through June 30, ~~2022:~~2023 in our condensed consolidated financials statements:


Iowa properties – November 2017	$	929,000
			SUL JV		Fantasia JVs		FPH JV		Total
Total investment		929,000	$	6,345,000	$	6,379,000	$	929,000	$	13,653,000
Income from equity-method investee		228,000
Income (loss) from equity-method investees			$	1,016,000	$	(83,000)	$	(112,000)	$	821,000
Distributions		(803,000)	$	(4,961,000)	$	(3,544,000)	$	(817,000)	$	(9,322,000)
Total FPH investment at June 30, 2022	$	354,000
Total investment at June 30, 2023			$	2,400,000	$	2,752,000	$	—	$	5,152,000
Number of properties				17		12		6		35
Number of beds				1,408		1,650		507		3,565

3326

Table of Contents

A summary of the condensed ~~consolidated~~combined financial data for the balance sheets and statements of ~~operations~~income (operations) for ~~the~~all unconsolidated ~~FPH JV is as follows:~~

Condensed Consolidated Balance Sheets of FPH JV:

June 30, 2022

December 31, 2021
Real estate properties, net

$
24,226,000

$
24,840,000
Cash and cash equivalents

1,944,000

1,650,000
Other assets

2,049,000

1,317,000
Total Assets:

$
28,219,000

$
27,807,000

Loans payable, net

$
20,536,000

$
20,764,000
Other liabilities

2,077,000

2,577,000
Members’ equity:

Fantasia JVs

5,252,000

4,207,000
Summit

354,000

259,000
Total Liabilities and Members’ Equity

$
28,219,000

$
27,807,000

Three Months Ended

Six Months Ended

June 30,

June 30,
Condensed Consolidated Statements of Income of FPH JV:

2022

2021

2022

2021
Total revenue

$
898,000

$
893,000

$
1,796,000

$
1,783,000
Property operating expenses

(142,000)

(138,000)

(276,000)

(263,000)
Net operating income

756,000

755,000

1,520,000

1,520,000
General and administrative expense

(36,000)

(36,000)

(73,000)

(73,000)
Depreciation and amortization expense

(307,000)

(307,000)

(614,000)

(614,000)
Income from operations

413,000

412,000

833,000

833,000
Interest expense

(247,000)

(252,000)

(490,000)

(503,000)
Amortization of debt issuance costs

(16,000)

(16,000)

(31,000)

(31,000)
Other income (expense)

380,000

(63,000)

1,429,000

629,000
Net income

$
530,000

$
81,000

$
1,741,000

$
928,000

Summit equity interest in FPH JV net income

$
53,000

$
8,000

$
174,000

$
93,000

~~As of June 30, 2022, the six properties of our unconsolidated equity-method investments in FPH JV, all of which are 100% leased on a triple net basis,~~Equity-Method Investments are as follows:


	June 30,			December 31,
Condensed Combined Balance Sheets:	2023			2022
Total Assets	$	245,563,000		$	249,540,000
Total Liabilities	$	181,846,000		$	185,857,000
Members Equity:
Summit	$	5,499,000	⁽¹⁾	$	5,676,000
JV Partners	$	58,218,000		$	58,007,000
Total Members Equity	$	63,717,000		$	63,683,000

~~Number of~~

~~Property~~

~~Location~~

~~Type~~

~~Beds~~

~~Accura Healthcare of Bancroft~~

~~Bancroft, Iowa~~

~~SNF/AL~~

~~Accura Healthcare of Milford~~

~~Milford, Iowa~~

~~SNF/AL~~

~~Accura Healthcare of Carroll~~

~~Carroll, Iowa~~

~~SNF/IL~~

~~Accura Healthcare of Cresco~~

~~Cresco, Iowa~~

~~SNF~~

~~Accura Healthcare of Marshalltown~~

~~Marshalltown, Iowa~~

~~SNF~~

~~Accura Healthcare of Spirit Lake~~

~~Spirit Lake, Iowa~~

~~SNF~~

~~Total:~~

~~453~~

(1)

~~Indiana JV~~

InAt June ~~2021, we sold~~30, 2023 and December 31, 2022, the aggregate balance of our ~~15% interest~~equity method investments in our condensed consolidated financials statements for each period presented of approximately $5.2 million is lower by approximately $0.3 million and $0.5 million, respectively, than the equity recognized in the ~~Indiana JV for approximately $5.4 million. The Indiana JV was not consolidated in our consolidated~~underlying Equity-Method Investments financial statements due to unrecorded losses and ~~was accounted for under the equity-method.~~

~~Table of Contents~~

~~The following reconciles our equity investment in the Indiana JV from inception through June 11, 2021:~~impairments.

Indiana properties – March 2019

$
4,906,000
Total investment

4,906,000
Loss from equity-method investee

(1,433,000)
Distributions

(1,577,000)
Total Indiana JV investment at June 11, 2021

1,896,000
Funds received from sale of interest in equity-method investment

5,411,000
Total gain on sale of Indiana JV equity-method investment at June 11, 2021

$
3,515,000


	Three Months Ended				Six Months Ended
	June 30,				June 30,
Condensed Combined Statements of Operations:	2023		2022		2023		2022
Total Revenue	$	9,186,000	$	9,536,000	$	18,006,000	$	19,136,000
Income (loss) from Operations	$	3,524,000	$	(93,000)	$	6,154,000	$	4,558,000
Net income (loss)	$	1,420,000	$	(2,062,000)	$	1,347,000	$	1,408,000

Summit equity interest in Equity-Method Investments net income (loss)	$	229,000	$	(1,066,000)	$	171,000	$	(424,000)
JV Partners interest in Equity-Method Investments net income (loss)	$	1,191,000	$	(996,000)	$	1,176,000	$	1,832,000

Distributions from Equity-Method Investments

For the six months ended June 30, ~~2022~~2023 and ~~2021,~~2022, we recorded distributions and cash received for distributions from our Equity-Method Investments as follows:


	Six Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2023		2022
Distributions	$	610,000	$	997,000	$	427,000	$	610,000

Cash received for distributions	$	546,000	$	1,605,000	$	413,000	$	546,000

~~Asset Management Fees~~

We serve as the manager or operating member (collectively, the manager) of our Equity-Method Investments and provide management services in exchange for fees and reimbursements. As the manager, we are paid an annual asset management fee for managing the properties owned by our Equity-Method Investments, as defined in the agreements. For the three months ended June 30, 2022 and 2021, we recorded approximately $0.2 million and $0.3 million, respectively, in asset management fees from our Equity-Method Investments. For the six months ended June 30, 2022 and 2021, we recorded approximately $0.3 million and $0.6 million, respectively, in asset management fees from our Equity-Method Investments.

Critical Accounting Policies

There have been no material changes to our critical accounting policies as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 as filed with the SEC on March 31, ~~2022 except for the additional revenue recognition – resident fees and services policy included in Note 2 to the accompanying Notes to Condensed Consolidated Financial Statements.~~2023.

Table of Contents

Results of Operations

Our results of operations are described below:

~~Table of Contents~~

Three Months Ended June 30, ~~2022~~2023 Compared to Three Months Ended June 30, ~~2021~~2022


	Three Months Ended						Three Months Ended
	June 30,						June 30,
	2022		2021		$ Change		2023		2022		$ Change
Total rental revenues	$	5,435,000	$	1,284,000	$	4,151,000	$	5,380,000	$	5,435,000	$	(55,000)
Resident fees and services income		863,000		—		863,000
Property operating and resident costs		(1,584,000)		(210,000)		(1,374,000)
Property operating costs								(746,000)		(766,000)		20,000
Resident fees and services revenue								1,633,000		863,000		770,000
Resident costs								(1,056,000)		(818,000)		(238,000)
Net operating income ⁽¹⁾		4,714,000		1,074,000		3,640,000		5,211,000		4,714,000		497,000
Asset management fees		165,000		295,000		(130,000)		147,000		165,000		(18,000)
Interest income from notes receivable		—		4,000		(4,000)
General and administrative		(1,132,000)		(862,000)		(270,000)		(1,091,000)		(1,132,000)		41,000
Depreciation and amortization		(1,848,000)		(393,000)		(1,455,000)		(1,810,000)		(1,848,000)		38,000
Income (loss) from equity-method investees		(1,131,000)		(550,000)		(581,000)		117,000		(1,131,000)		1,248,000
Gain on sale of equity-method investment		—		3,515,000		(3,515,000)
Other income		161,000		6,000		155,000		100,000		161,000		(61,000)
Interest expense		(3,105,000)		(516,000)		(2,589,000)		(4,336,000)		(3,105,000)		(1,231,000)
Net (loss) income		(2,176,000)		2,573,000		(4,749,000)
Net loss								(1,662,000)		(2,176,000)		514,000
Noncontrolling interests’ share in (income)		(18,000)		(22,000)		4,000		(19,000)		(18,000)		(1,000)
Net (loss) income applicable to common stockholders	$	(2,194,000)	$	2,551,000	$	(4,745,000)
Net loss applicable to common stockholders							$	(1,681,000)	$	(2,194,000)	$	513,000

(1)

Net operating income (“NOI”) is a non-GAAP supplemental measure used to evaluate the operating performance of real estate properties. We define NOI as total rental revenues, resident fees and ~~service income~~services revenue less property operating and resident costs. NOI excludes asset management fees, ~~interest income from notes receivable,~~ general and administrative expense, depreciation and amortization, income (loss) from equity-method investees, other income, and interest expense. We believe NOI provides investors relevant and useful information because it measures the operating performance of the REIT’s real estate at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess and compare property-level performance. We believe that net income (loss) is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect the aforementioned excluded items. Additionally, NOI as we define it may not be comparable to NOI as defined by other REITs or companies, as they may use different methodologies for calculating NOI.

Total rental revenues for our properties includes rental revenues and tenant reimbursements for property taxes and insurance. Resident fees and services income are generated from ~~Pennington Gardens Operations (effective February 2022)~~the Operated Properties. Property operating costs include insurance, and ~~Sundial Operations (effective June 2022) (collectively “Operated Properties”). Property operating~~property taxes, and resident costs ~~include insurance, property taxes, resident costs~~are related to the Operated ~~Properties of $0.8 million and other operating expenses.~~Properties. Net operating income increased approximately ~~$3.6~~$0.5 million for the three months ended June 30, 2023 compared to the three months ended June 30, 2022 primarily due to Sundial being included in our condensed consolidated financials for one month in the three months ended June 30, 2022 compared to three months in the three months ended June 30, ~~2021 primarily due to rental revenues generated from the CA3 and GA8 acquisitions in July and December 2021, respectively.~~

Asset management fees decreased approximately $0.1 million for the three months ended June 30, 2022 compared to the three months ended June 30, 2021 due to the sale of the Indiana JV in June 2021 (see Note 5 to the accompanying Notes to Condensed Consolidated Financial Statements).2023.

The net ~~increase in general and administrative expenses of $0.3 million for the three months ended June 30, 2022 compared~~change from loss to ~~the three months ended June 30, 2021 is primarily due to an increase in legal and accounting fees of $0.2 million.~~

The net increase in depreciation and amortization of $1.5 million and interest expense of $2.6 million for the three months ended June 30, 2022 compared to the three months ended June 30, 2021 is primarily due to CA3 and GA8 acquisitions in July and December 2021.

~~The net increase in loss~~income from equity-method investees of approximately ~~$0.6~~$1.2 million ~~from our equity-method investments for the three months ended June 30, 2022~~ is mainly due to the impairment loss of $1.2 million related to the Fantasia I JV ~~and~~in the ~~net loss for~~ three months ended June 30, ~~2021 related~~2022.

The increase in interest expense of $1.2 million for the three months ended June 30, 2023 compared to the ~~Indiana JV of $0.7 million~~three months ended June 30, 2022 is due to an increase of approximately 4% in interest rates on approximately $139.0 million of debt for the ~~sale of our interest in June 2021.~~CA3 and GA8 Properties.

3628

Table of Contents

Six Months Ended June 30, ~~2022~~2023 Compared to Six Months Ended June 30, ~~2021~~2022


	Six Months Ended						Six Months Ended
	June 30,						June 30,
	2022		2021		$ Change		2023		2022		$Change
Total rental revenues	$	10,976,000	$	2,208,000	$	8,768,000	$	10,747,000	$	10,976,000	$	(229,000)
Resident fees and services income		1,271,000		—		1,271,000
Property operating and resident costs		(2,732,000)		(430,000)		(2,302,000)
Property operating costs								(1,552,000)		(1,539,000)		(13,000)
Resident fees and services revenue								3,002,000		1,271,000		1,731,000
Resident costs								(2,266,000)		(1,193,000)		(1,073,000)
Net operating income ⁽¹⁾		9,515,000		1,778,000		7,737,000		9,931,000		9,515,000		416,000
Asset management fees		330,000		624,000		(294,000)		295,000		330,000		(35,000)
Interest income from notes receivable		—		13,000		(13,000)
General and administrative		(2,180,000)		(2,493,000)		313,000		(2,200,000)		(2,180,000)		(20,000)
Depreciation and amortization		(3,685,000)		(792,000)		(2,893,000)		(3,615,000)		(3,685,000)		70,000
Loss from equity-method investees		(489,000)		(785,000)		296,000
Gain on sale of equity-method investment		—		3,515,000		(3,515,000)
Income (loss) from equity-method investees								242,000		(489,000)		731,000
Other income		163,000		11,000		152,000		196,000		163,000		33,000
Interest expense		(6,136,000)		(1,038,000)		(5,098,000)		(8,470,000)		(6,136,000)		(2,334,000)
Net (loss) income		(2,482,000)		833,000		(3,315,000)
Net loss								(3,621,000)		(2,482,000)		(1,139,000)
Noncontrolling interests’ share in (income)		(37,000)		(40,000)		3,000		(36,000)		(37,000)		1,000
Net (loss) income applicable to common stockholders	$	(2,519,000)	$	793,000	$	(3,312,000)
Net loss applicable to common stockholders							$	(3,657,000)	$	(2,519,000)	$	(1,138,000)

Total rental revenues for our properties includes rental revenues and tenant reimbursements for property taxes and insurance. Resident fees and services income are generated from the Operated Properties. Property operating and resident costs include insurance, property taxes and resident costs are related to the Operated ~~Properties of $1.2 million and other operating expenses.~~Properties. Net operating income increased approximately ~~$7.7~~$0.4 million for the six months ended June 30, 2023 compared to the six months ended June 30, 2022 primarily due to Sundial being included in our condensed consolidated financials for one month in the six months ended June 30, 2022 compared to six months in the six months ended June 30, ~~2021 primarily due to rental revenues generated from the CA3 and GA8 acquisitions in July and December 2021, respectively.~~

Asset management fees decreased approximately $0.3 million for the six months ended June 30, 2022 compared to the six months ended June 30, 2021 due to the sale of the Indiana JV in June 2021 (see Note 5 to the accompanying Notes to Condensed Consolidated Financial Statements).2023.

The net ~~decrease in general and administrative expenses of $0.3 million for the six months ended June 30, 2022 compared~~change from loss to ~~the six months ended June 30, 2021 is primarily due to the write off of expenses associated with a terminated transaction~~income from equity-method investees of approximately ~~$0.6~~$0.7 million ~~in March 2021 offset by an increase in legal and accounting fees of $0.3 million.~~

~~The net increase in depreciation and amortization of $2.9 million and interest expense of $5.0 million for the six months ended June 30, 2022 compared to the six months ended June 30, 2021~~ is ~~primarily due to CA3 and GA8 acquisitions in July and December 2021.~~

~~The net decrease of approximately $0.3 million in loss from our equity-method investments for the six months ended June 30, 2022 is primarily~~mainly due to the impairment loss of $1.2 million related to the Fantasia I JV ~~offset by the sale of the property~~ in the ~~Fantasia I JV (resulting~~six months ended June 30, 2022.

The increase in ~~loss from the Fantasia I JV~~interest expense of ~~approximately $0.9~~$2.3 million for the six months ended June 30, 2022 versus income for the six months ended June 30, 2021 of $0.1 million), offset by the net loss for six months ended June 30, 2021 related to the Indiana JV of $1.3 million versus no loss for the six months ended June 30, 2022 due to the sale of our interest in the Indiana JV in June 2021.

~~The net decrease in gain on sale of equity-method investment of approximately $3.5 million for the six months ended June 30, 2022~~2023 compared to the six months ended June 30, ~~2021~~2022 is due to an increase of approximately 4% in interest rates on approximately $139.0 million of debt for the sale of our equity interest in the Indiana JV (see Note 5 to the accompanying Notes to Condensed Consolidated Financial Statements for further information related to the sale of our interest in the Indiana JV in June 2021).CA3 and GA8 Properties.

Liquidity and Capital Resources

As of June 30, ~~2022,~~2023, we had approximately ~~$13.1~~$11.1 million in cash and cash equivalents on hand. During March 2023, in response to the banking crisis, we transferred cash balances in excess of FDIC-insured limits from a smaller regional bank to a multi-national bank with more liquidity and a significantly larger balance sheet. We will continue to address the banking environment and make appropriate changes as necessary. To date, we have not experienced losses or lack of access to cash in our cash and cash equivalent accounts. Based on current conditions, we believe that we have sufficient capital resources to sustain operations.

Going forward, we expect our primary sources of cash to be rental revenues, ~~joint venture~~equity-method investment distributions and asset management fees. In addition, we may increase cash through the sale of additional properties, which may result in the deconsolidation of properties we already own, or borrowing against currently-owned properties. For the foreseeable future, we expect our primary uses of cash to be for

~~Table of Contents~~

funding future acquisitions, investments in joint ventures, operating expenses, interest expense on outstanding indebtedness and the repayment of principal on loans payable. We may also incur expenditures for renovations of our existing properties, making our facilities more appealing in their market.

Seven of our debt obligations are long-term, fixed rate U.S. Department of Housing and Urban Development (“HUD”)-insured loans that mature between 2039 and 2055. The other debt obligations are short-term loans that mature in July 2024 through December 2026 with variable interest rates ~~starting at approximately 4% through 12%~~(see Note 4 to the accompanying Notes to Condensed Consolidated Financial Statements). Due to the current environment of increasing interest rates, this may have a negative effect on our results of operations and ~~based on the Secured Overnight Financing Rate (“SOFR”) or the bank’s base rate as documented in all of our loan agreements. We expect to~~for that reason, we may refinance these short-term loans with long-term, fixed rate HUD-insured ~~debt.~~debt, other long-term debt, or a combination of debt and equity in 2023.

Table of Contents

Our liquidity will increase if cash from operations exceeds expenses, we receive net proceeds from the sale of whole or partial interest in a property or properties, or refinancing results in excess loan proceeds. Our liquidity will decrease as proceeds are expended in connection with our acquisitions and operation of properties. In regard to our Operated Properties, our intent is to stabilize the operations of the facilities and execute long-term triple-net leases with either a new or the existing manager/operator.

Credit Facilities and Loan Agreements

As of June 30, ~~2022,~~2023, we had debt obligations of approximately ~~$184.3~~$183.2 million. The outstanding balance by lender is as follows (see Note 4 to the accompanying Notes to Condensed Consolidated Financial Statements for further information regarding our refinancing arrangements):

●

Capital One Multifamily Finance, LLC (HUD-insured) – approximately ~~$10.1~~$10.0 million maturing September 2053

●

Lument Capital (formerly ORIX Real Estate Capital, LLC) (HUD-insured) – approximately ~~$35.4~~$34.4 million maturing from September 2039 through April 2055

●

CIBC Bank, USA - approximately $106.0 million maturing from July 2024 to December 2024

●

Oxford Finance LLC – approximately $32.8 million maturing from March 2025 to December 2026

Distributions

We made no stockholder distributions during the ~~three~~six months ended June 30, ~~2022.~~2023.

Funds from Operations (“FFO”)

FFO is a non-GAAP supplemental financial measure that is widely recognized as a measure of REIT operating performance. We compute FFO in accordance with the definition outlined by the National Association of Real Estate Investment Trusts (“NAREIT”). NAREIT defines FFO as net income (loss), computed in accordance with GAAP, excluding gains or losses from sales of property, plus depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures.

~~Table of Contents~~

Our FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or that interpret the current NAREIT definition differently than we do. We believe that FFO is helpful to investors and our management as a measure of operating performance because it excludes real estate depreciation and amortization, gains and losses from property dispositions, impairments and extraordinary items, and as a result, when compared period to period, reflects the impact on operations from trends in occupancy rates, rental rates, operating costs, development activities, general and administrative expenses, and interest costs, which is not immediately apparent from net income. Historical cost accounting for real estate assets in accordance with GAAP implicitly assumes that the value of real estate diminishes predictably over time. Since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered the presentation of operating results for real estate companies that use historical cost accounting alone to be insufficient. As a result, our management believes that the use of FFO, together with the required GAAP presentations, provide a more complete understanding of our performance. Factors that impact FFO include start-up costs, fixed costs, delays in buying assets, lower yields on cash held in accounts pending investment, income from portfolio properties and other portfolio assets, interest rates on acquisition financing and operating expenses. FFO should not be considered as an alternative to net income (loss), as an indication of our performance, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions.

Table of Contents

The following is the reconciliation from net income (loss) applicable to common stockholders, the most direct comparable financial measure calculated and presented with GAAP, to FFO for the three and six months ended June 30, ~~2022~~2023 and ~~2021:~~2022:

Three Months Ended

Six Months Ended

June 30,

June 30,


2022

2021

2022

2021

Net (loss) income applicable to common stockholders (GAAP)

$
(2,194,000)

$
2,551,000

$
(2,519,000)

$
793,000

Adjustments:

Depreciation and amortization

1,843,000

393,000

3,674,000

792,000

Depreciation and amortization related to non-controlling interests

(11,000)

(9,000)

(22,000)

(19,000)

Depreciation related to Equity-Method Investments

226,000

388,000
⁽¹⁾

456,000

815,000
⁽²⁾
Impairment on real estate property in Fantasia I (included in loss from Equity-Method Investments)

1,200,000

—

1,200,000

—

Gain on sale of property in Fantasia I (included in income from Equity-Method Investments)

—

—

(437,000)

—

Gain on sale of equity-method investment

—

(3,515,000)

—

(3,515,000)

Funds provided by (used in) operations (FFO) applicable to common stockholders

$
1,064,000

$
(192,000)
⁽¹⁾

2,352,000

$
(1,134,000)
⁽²⁾
Weighted-average number of common shares outstanding - basic

23,027,978

23,027,978

23,027,978

23,027,978

FFO per weighted average common shares - basic

$
0.05

$
(0.01)

$
0.10

$
(0.05)

Weighted-average number of common shares outstanding - diluted

23,027,978

23,553,606

23,027,978

23,553,606

FFO per weighted average common shares - diluted

$
0.05

$
(0.01)

$
0.10

$
(0.05)

~~(1)~~

~~Revised to exclude $0.1 million above-market lease amortization.~~

~~(2)~~

~~Revised to exclude $0.2 million above-market lease amortization.~~


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2023		2022		2023		2022
Net (loss) income applicable to common stockholders (GAAP)	$	(1,681,000)	$	(2,194,000)	$	(3,657,000)	$	(2,519,000)
Adjustments:
Depreciation and amortization		1,797,000		1,843,000		3,595,000		3,674,000
Depreciation and amortization related to non-controlling interests		(10,000)		(11,000)		(20,000)		(22,000)
Depreciation related to Equity-Method Investments		183,000		226,000		366,000		456,000
Impairment on real estate property in Fantasia I (included in loss from Equity-Method Investments)		—		1,200,000		—		1,200,000
Gain on sale of property in Fantasia I JV (included in income from Equity-Method Investments)		—		—		—		(437,000)
Funds provided by (used in) operations (FFO) applicable to common stockholders	$	289,000	$	1,064,000		284,000	$	2,352,000
Weighted-average number of common shares outstanding - basic		23,027,978		23,027,978		23,027,978		23,027,978
FFO per weighted average common shares - basic	$	0.01	$	0.05	$	0.01	$	0.10
Weighted-average number of common shares outstanding – diluted		23,496,475		23,553,606		23,496,475		23,553,606
FFO per weighted average common shares - diluted	$	0.01	$	0.05	$	0.01	$	0.10

Subsequent Events

~~None.~~See Note 14 to the accompanying Notes to Condensed Consolidated Financial Statements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not applicable.

~~Table of Contents~~

Item 4. Controls and Procedures.

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our senior management, including our Chief Executive Officer (Principal Executive Officer) and our Chief Financial Officer (Principal Financial Officer), to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) evaluated the effectiveness of our disclosure controls and procedures and concluded that the disclosure controls and procedures were effective as of the end of the period covered by this report.

There have been no changes in our internal control over financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.Legal Proceedings.

See Note 12 to the accompanying Notes to Condensed Consolidated Financial Statements for a summary of our material legal proceedings.

Table of Contents

Item 1A.Risk Factors.

There have been no material changes to the Risk Factors described in Part I, Item 1A, Risk Factors, in our Annual Report on Form 10-K for the year ended December 31, ~~2021, as updated by Part II, Item 1A, Risk Factors in our quarterly report on Form 10-Q for the quarter ended March 31,~~ 2022.

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

(a)	We did not sell any equity securities that were not registered under the Securities Act of 1933, as amended, during the periods covered by this Form 10-Q.

(b)	Not applicable.

(c)	During the six months ended June 30, ~~2022,~~2023, we redeemed no shares pursuant to our stock repurchase program.

Item 3.Defaults Upon Senior Securities.

None.

Item 4.Mine Safety Disclosures.

None.

Item 5.Other Information.

None.

4032

Table of Contents

Item 6.Exhibits.


Ex.		Description
3.1		Amendment and Restatement of Articles of Incorporation of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K filed on March 24, 2006).

3.2		Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.3 to Post-Effective Amendment No. 1 to the Registration Statement on Form S-11 (No. 333-121238) filed on December 23, 2005).

3.3		Articles of Amendment of the Company dated October 16, 2013 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 22, 2013).

3.4		Second Articles of Amendment and Restatement of Articles of Incorporation of the Company dated June 30, 2010 (incorporated by reference to Exhibit 3.4 to the Company’s Annual Report on Form 10-K filed on March 20, 2015).

4.1		Subscription Agreement (incorporated by reference to Appendix A to the prospectus included on Post-Effective Amendment No. 2 to the Registration Statement on Form S-11 (No. 333-155640) filed on April 16, 2010 (“Post-Effective Amendment No. 2”)).

4.2		Statement regarding restrictions on transferability of shares of common stock (to appear on stock certificate or to be sent upon request and without charge to stockholders issued shares without certificates) (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form S-11 (No. 333-121238) filed on December 14, 2004).

4.3		Amended and Restated Distribution Reinvestment Plan (incorporated by reference to Appendix B to the prospectus dated April 16, 2010 included on Post-Effective Amendment No. 2).

4.4		2015 Omnibus Incentive Plan dated October 28, 2015 (incorporated by reference to Appendix A to the Definitive Proxy Statement on Schedule 14A filed on September 28, 2015).

~~10.1~~		Temporary Space License Agreement between Lakehills CM-CG LLC, a Delaware limited liability company, as licensor, and Summit Healthcare REIT, Inc., as licensee, dated April 1, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 7, 2022).

~~10.2~~		Standard Office lease between Lakehills CM-CG LLC, a Delaware limited liability company, as landlord, and Summit Healthcare REIT, Inc., as tenant, dated April 1, 2022 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 7, 2022).

31.1		Certification of Principal Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Principal Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32		Certification of Principal Executive Officer and Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as ~~created by~~adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.1		The following information from the Company’s quarterly report on Form 10-Q for the quarter ended June 30, ~~2022,~~2023, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations; (iii) Condensed Consolidated Statements of Cash Flows.

104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

4133

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this quarterly report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SUMMIT HEALTHCARE REIT, INC.

	/s/ ~~Kent Eikanas~~Elizabeth A. Pagliarini
Date: August ~~12, 2022~~11, 2023	~~Kent Eikanas~~Elizabeth A. Pagliarini
	Chief Executive Officer
	(Principal Executive Officer)

	/s/ ~~Elizabeth A. Pagliarini~~Sharyn I. Grant
Date: August ~~12, 2022~~11, 2023	~~Elizabeth A. Pagliarini~~Sharyn I. Grant
	Chief Financial Officer
	(Principal Financial Officer)

4234


	As previously reported		Increase (decrease)		As reclassified
Real estate assets, net	$	192,862,000	$	(13,760,000)	$	179,102,000
Intangible lease assets, net	$	—	$	14,687,000	$	14,687,000
Other assets, net	$	1,349,000	$	(927,000)	$	422,000
Total assets	$	219,126,000	$	—	$	219,126,000


			Fantasia		Fantasia		Fantasia		FPH		Combined
	SUL JV		JV		II JV		III JV		JV		Total
Revenue	$	5,240,000	$	617,000	$	716,000	$	2,065,000	$	898,000	$	9,536,000
Income (loss) from operations	$	1,469,000	$	(3,499,000)	$	507,000	$	1,017,000	$	413,000	$	(93,000)
Net income (loss)	$	179,000	$	(3,548,000)	$	276,000	$	501,000	$	530,000	$	(2,062,000)
Summit interest in Equity-Method Investments net income (loss)	$	18,000	$	(1,242,000)	$	55,000	$	50,000	$	53,000	$	(1,066,000)	⁽¹⁾


JV 2 Properties (Colorado, Oregon and Virginia) – April 2015	$	1,100,000
Creative Properties (Texas) – October 2015		837,000
Cottage Properties (Wisconsin) – December 2015		1,811,000
Riverglen (New Hampshire) – April 2016		424,000
Delaware Properties – September 2016		1,846,000
Total investments		6,018,000
Income from equity-method investee		1,634,000
Distributions		(4,370,000)
Total investment at June 30, 2022	$	3,282,000


	Three Months Ended				Six Months Ended
	June 30,				June 30,
Condensed Consolidated Statements of Income of SUL JV:	2022		2021		2022		2021
Total revenue	$	5,240,000	$	5,091,000	$	10,435,000	$	10,267,000
Property operating expenses		(2,644,000)		(1,902,000)		(5,120,000)		(4,157,000)
Net operating income		2,596,000		3,189,000		5,315,000		6,110,000
General and administrative expense		(104,000)		(108,000)		(205,000)		(208,000)
Depreciation and amortization expense		(1,023,000)		(1,271,000)		(2,043,000)		(2,545,000)
Income from operations		1,469,000		1,810,000		3,067,000		3,357,000
Interest expense		(1,075,000)		(1,155,000)		(2,179,000)		(2,314,000)
Amortization of debt issuance costs		(216,000)		(51,000)		(265,000)		(104,000)
Other income (expense)		1,000		5,000		3,000		(152,000)
Net income	$	179,000	$	609,000	$	626,000	$	787,000

Summit equity interest in SUL JV net income	$	18,000	$	61,000	$	63,000	$	79,000


Summit Fantasia Holdings, LLC – October 2016	$	2,593,000
Summit Fantasia Holdings II, LLC – February 2017		1,923,000
Summit Fantasia Holdings III, LLC – August 2017		1,954,000
Total investment		6,470,000
Income from Fantasia JVs		813,000
Distributions		(3,396,000)
Total Fantasia investments at June 30, 2022	$	3,887,000


	June 30,		December 31,
Condensed Combined Balance Sheets of Fantasia JVs:	2022		2021
Real estate properties, net⁽²⁾	$	84,443,000	$	88,908,000
Cash and cash equivalents		6,050,000		8,135,000
Assets held for sale ⁽¹⁾		—		10,454,000
Other assets		7,648,000		6,834,000
Total Assets:	$	98,141,000	$	114,331,000

Loans payable, net	$	62,107,000	$	67,154,000
Liabilities held for sale ⁽¹⁾		—		7,537,000
Other liabilities		7,322,000		8,885,000
Members’ equity:
Fantasia JVs		24,760,000		25,967,000
Summit		3,952,000		4,788,000
Total Liabilities and Members’ Equity	$	98,141,000	$	114,331,000


Indiana properties – March 2019	$	4,906,000
Total investment		4,906,000
Loss from equity-method investee		(1,433,000)
Distributions		(1,577,000)
Total Indiana JV investment at June 11, 2021		1,896,000
Funds received from sale of interest in equity-method investment		5,411,000
Total gain on sale of Indiana JV equity-method investment at June 11, 2021	$	3,515,000